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Abstract
ALTERNATIVE REGULATION OF THE ALGINATE ALGD OPERON BY AN ACTIVATED
ALGB IN NONMUCOID PSEUDOMONAS AERUGINOSA IS DEPENDENT ON SIGMA 54
By Jean H. Kim, Ph.D.
A dissertation submitted in partial fulfillment of the requirements for the degree of
Doctor of Philosophy at Virginia Commonwealth University
Virginia Commonwealth University, 2010
Major Director: Dennis E. Ohman, Ph.D.
Professor and Chair, Department of Microbiology and Immunology
Alginate overproduction by Pseudomonas aeruginosa, which causes a mucoid
phenotype, is a major virulence factor associated with chronic pulmonary infections in
cystic fibrosis patients. Expression of the algD operon for alginate biosynthesis requires
three major regulators in association with the ECF sigma factor, σ22, in mucoid strains
that are typically defective in anti-sigma factor, MucA. One such algD regulator is AlgB,
a member of the NtrC family of two-component systems, which typically utilize σ54.
However, neither σ54 nor the cognate sensor kinase (KinB) of AlgB are required for algD
expression in such mucoid strains. I hypothesized that KinB-phosphorylated AlgB must
play some role in gene regulation, and so I sought to construct an overactive AlgB that
simulated kinase-phosphorylation. I took a predictive approach and genetically
introduced substitutions in AlgB that had been shown to activate DctD, a close
homologue of AlgB in Rhizobium (55). When one such substitution, AlgBE125K, was
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transferred to a nonmucoid P. aeruginosa PAO ΔalgB-kinB (JK159) strain, alginate
overproduction was observed. Interestingly, introduction of an algT mutation to
remove σ22 did not block alginate production induced by AlgBE125K; although, it did
stimulate the production of alginate in the presence of AlgBwt in trans to similar levels
induced by the overactive mutant. In contrast, introduction of an rpoN mutation
showed that alginate production mediated by AlgBwt and AlgBE125K was σ54 dependent.
The increase in expression of alginate by AlgBwt in the presence of σ54 and the absence
of σ22 suggested a competition between the sigma factors for binding to PalgD.
Biochemical assays were conducted to assess the overactive property of AlgBE125K. For
the ATPase assay, an equivalent amount of ATP hydrolysis was observed between the
mutant and the wild type AlgB proteins. Slight differences seen for the EMSA data
suggested possible higher order complex formation for AlgBE125K compared to AlgBwt.
Collectively, these results suggest that in wild-type (MucA+) P. aeruginosa, expression
of the algD operon is dependent on the phosphorylation of AlgB by KinB in a typical
two-component fashion that is triggered by some as yet unknown environmental
stimulus.

Chapter 1: Introduction

Pseudomonas aeruginosa
Members of the family Pseudomonadaceae are ecologically significant and the
most diverse group of bacteria. They are generally straight or slightly curved
nonsporulating rods with one or more polar or lateral flagella used for motility (59).
Commonly found in the soil and water, these bacteria are important saprophytes that
degrade and decompose organic matter contributing to the carbon cycle (71).

Pseudomonas aeruginosa, a gram-negative opportunistic pathogen, is a member
of the family Pseudomonadaceae. As is true with opportunistic pathogens, P.

aeruginosa does not cause infection in healthy organisms, however, when given the
occasion such as reduced immunity or a temporary disruption of protective barriers, the
bacterium is pathogenic in plants and mammals. This ubiquitous organism is extremely
versatile and can adapt to most environments including those typically presumed
uninhabitable. P. aeruginosa have been isolated from unusual liquid sources such as
distilled water, ophthalmic solutions, and antiseptic solutions. They have also been
found on inanimate surfaces that are intermittently exposed to moisture including
forceps, utensils, sinks, and taps. Their unique ability to adapt and persist in such
unforgiving conditions is due to the organisms’ capacity to survive on extremely limiting
amounts of nutrients and to utilize a variety of carbon sources (21, 49, 71).
1
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Pathogenesis
A vast number of species have been classified under the genus Pseudomonas,
however, P. aeruginosa is the species most commonly associated with human disease in
the U.S. This organism has become clinically important because of the myriad of minor
and severe infections it can cause anywhere throughout the body. However, these
infections can only be established when protective barriers are destroyed and/or the
host humoral and cellular defenses are impaired. Some minor infections include
folliculitis and otitis externa (swimmer’s ear), which might be self-limiting or can easily
be treated with topical antibiotics. More serious infections such as ocular kerititis,
endocarditis, meningitis, infections of burns and other severe skin wounds, and
pulmonary infections can be debilitating or lead to septicemia ultimately resulting in
death (22, 56, 71).

P. aeruginosa is also an important causative agent of nosocomial infections,
accounting for 11-13.8% of patients that are infected by this bacterium. The
percentage is even higher in intensive care units (ICUs) where 13.2-22.6% of these
patients are infected by P. aeruginosa (19). This is not surprising, since the protective
defenses of patients are depressed and the bacteria can persist on fomites and in other
unusual moist environments throughout the hospital. Survival of these opportunistic
pathogens is not only a result of their unique metabolic capabilities but also their
possession of multiple virulence factors (37) and their ability to acquire mechanisms of
antibiotic resistance (9, 44) constantly adding to their repertoire. These mechanisms
for resistance are truly impressive including enzymes that modify drugs, enzymes that
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modify targets, a number of multidrug efflux pumps, and a decrease in outer
membrane permeability (19, 77).
A more notable infection caused by P. aeruginosa is the one seen in cystic
fibrosis (CF) patients. This bacterium is the leading cause of morbidity and mortality of
CF-afflicted individuals demanding for more research. Cystic fibrosis is an autosomal
recessive disorder resulting from mutations in the gene that codes for the cystic fibrosis
transmembrane conductance regulator, CFTR. The CFTR is an ATP-binding cassette,
ABC, transport protein responsible for the channeling of chloride ions across the apical
membranes of epithelial cells. Although this transport protein regulates levels of
chloride ions, it is also important for the regulation of other ion channels transporting
sodium, and potassium. The disregulation of these channels results in the abnormal
secretion of a viscous mucus deficient in both water and electrolytes. Passages in the
lungs and intestinal organs become obstructed causing damage and impairment of their
normal functions. People with CF also present with a high level of salt secreted from
their sweat glands. This is due to poor reabsorption of sodium ions since their chloride
counter ions are not reabsorbed by the mutated CFTR, which is the only pathway
mediating this process (52, 70).
The lung environment of an individual with CF is ideal for bacterial colonization.
The thick mucus secretion lining the surface of the lungs is unable to be cleared by the
damaged cilia providing a surface for adherence and a niche for pathogens. Early
colonizers infecting the lungs of infants are generally Staphylococcus aureus and

Haemophilus influenzae. P. aeruginosa is seen later in toddlers (20% of one-year olds
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and 33% of three-year olds) and is subsequently dominant in adults (80-90%). It is
believed that these early bacterial colonizers assist in the establishment of
pseudomonads. Ultimately, P. aeruginosa produces chronic pulmonary infections that
eventually lead to impairment of lung function and possibly death. Their ability to
persist and maintain infection is primarily due to the antibiotic resistance mechanisms
they possess as mentioned above. Both S. aureus and H. influenzae are treatable with
aggressive antibiotic therapy (14, 52, 82). Even P. aeruginosa can be eradicated when
caught early using the same method of treatment, however, elimination is impossible
once infection is established. A development of long-term suppressive antibiotic
treatments has benefited patients suffering from chronic Pseudomonas infections.
These antibiotic treatment methods and methods for preventing infection have
increased the life expectancy of CF patients from 25 years in 1985 to 38 years in 2007
(14, 47). Although improvements have been made to prolong the lives of CF patients,
new challenges continually arise such as the emergence of pan-resistance seen with

Pseudomonas aeruginosa magnifying the difficulty in treatment of infections (9, 44).

Alginate and its role in pulmonary infection
In addition to the number of antibiotic resistance mechanisms possessed by P.

aeruginosa, an important virulence factor, alginate, is also present in strains isolated
from CF patients contributing to the bacterium’s persistence. Alginate is a secreted
linear exopolysaccharide composed of two uronic acids, D-mannuronate and its C-5
epimer, L-guluronate, joined together via a β−1, 4 linkage. Further modifications to D-
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mannuronate can occur at the C-2 and C-3 hydroxyl groups with the addition of acetyl
moieties at either one or both sites (27). Initial Pseudomonas infections observed in
the lungs of CF patients are negative for alginate production and have a nonmucoid
appearance. However, persistent colonizers, eventually secrete copious amounts of
alginate giving the bacterial colonies a mucoid phenotype. Interestingly, mucoid forms
of P. aeruginosa occur infrequently. Colonies isolated from infection sites outside of a
CF lung are rarely alginate-producing strains, and patients with other respiratory
diseases are generally colonized by strains that do not undergo mucoid conversion.
Less than 2% of these individuals have alginate-producing bacteria. However, the
incidence of mucoid isolates obtained from CF individuals is high with 90% of patients
containing this form (52). The conversion to mucoid phenotype was discovered to be a
result of mutations in the mucA gene coding for the anti-sigma factor to sigma 22 (35).
FRD1, an alginate-producing strain isolated from a CF lung, carries a mucA22 mutation,
which is a single nucleotide deletion resulting in a frame shift mutation that produces a
nonfunctioning anti-sigma factor (48). This deregulation of sigma 22 allows for
continued transcriptional activation of alginate creating a mucoid Pseudomonas

aeruginosa.
Alginate offers benefits to P. aeruginosa microcolonies that are found in the
lungs. This virulence factor allows for mature biofilms to develop with extensive
architecture providing protection against aggressive antibiotic treatments (33). Alginate
also mediates the survival of Pseudomonas within the harsh environment of the CF
lung. Colonization by microorganisms recruits a variety of host immune cells
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administering their normal defense mechanisms. The exopolysaccharide protects the
bacteria from these defenses by scavenging free radicals (reactive oxygen and nitrogen
intermediates) released by macrophages, providing a physical and chemical barrier
against defensins and phagocytic cells, and impeding neutrophil chemotaxis and
complement binding and activation (19, 64). These multiple host evasion mechanisms
mediated by a single virulence factor give P. aerugonisa a significant survival
advantage, and the ability to persist and maintain infection.

Alginate gene regulation
The transcriptional regulation of the alginate operon is extremely complex
involving multiple factors that function either directly or indirectly in this process. The
operon consists of all but one of the biosynthetic genes, algC, which is located
elsewhere on the chromosome. Genes involved in the regulation of alginate are found
throughout the genome (Figure 1A and B). The direct regulators of PalgD, which bind to
the promoter, include the alternative sigma factor (σ22, AlgT/U), AlgR, AmrZ (AlgZ), and
AlgB. Their binding positions are shown in Figure 2A. All three of these regulators are
essential for the maximum production of alginate and the loss of any one results in the
attenuation of this virulence factor (5, 6, 43, 58, 92).
Indirect regulation of the alginate operon is mediated by the alternative sigma
factor, sigma 22 (AlgT/U), as shown in Figure 2B. This sigma factor, a member of the
extracytoplasmic function (ECF) subfamily, undergoes autoregulation and positively
regulates the transcription of AmrZ, AlgR, and AlgB (5, 58, 92). Posttranslational
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regulation of sigma 22 also occurs involving two negative regulators, MucA and MucB,
which are part of the algT operon. MucA, the anti-sigma factor, is a transmembrane
protein found in the inner membrane with the N-terminal domain in the cytoplasm and
the C-terminal domain in the periplasm (50). AlgT is tethered to the membrane in the
cytoplasm by MucA, which also binds to MucB in the periplasm. In response to cell wall
stress, sequential proteolytic cleavage of MucA occurs with the C-terminal domain
cleaved by AlgW followed by the N-terminal domain cleaved by YaeL. Subsequent
degradation of the N-terminus results in the release of sigma 22 allowing for
transcriptional activation of regulated promoters (63, 90). Two of the sigma 22
regulated proteins, AlgB and AlgR, have been shown to be homologous to response
regulators of two-component systems, however, AlgB’s role in this process is lacking
(16, 91).
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Figure 1. Organization of the biosynthetic and regulatory genes of alginate.
A. The alginate operon. Twelve of the thirteen biosynthetic genes are arranged in an
operon. B. Circular representation of Pseudomonas aeruginosa genome. The location
of algC and the regulatory genes involved in alginate production are indicated within
the genome.
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Figure 2. Direct and indirect transcriptional regulation of alginate. A. The
location of regulator binding sites mapped to the algD promoter, PalgD. B. Diagram
showing the indirect regulation of alginate facilitated by sigma 22 with its
autoregulation, regulation of AlgB, AlgR, and AmrZ, and by its negative regulators.
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Two-component systems.
The two-component regulatory system is an important and effective signaling
mechanism utilized by bacteria for sensing their surroundings allowing them to adapt to
dynamic environments and to survive extreme conditions. This process in its
fundamental form involves two proteins: the cognate sensor kinase (histidine kinase)
and the response regulator, which are generally located together in a single operon. A
more complicated variant can also be found employing intermediate receiver or
phosphotransfer proteins providing an added level of regulation and an increased
precision of response (83). A genome wide screening of genes in P. aeruginosa
encoding proteins involved in two-component systems identified 63 putative histidine
kinases and 64 putative response regulators which is reported to be the highest number
of two-component systems for any bacteria. This is not surprising, however, since

Pseudomonas is found in a variety of environments requiring the bacterium to adapt
rapidly (67). As shown in Figure 3, the histidine kinase senses a stimulus in the
environment, which can either be chemical or physical such as interactions with host
cells, or changes in pH, ions, temperature, oxygen pressure, and osmolarity, resulting in
kinase autophosphorylation at a conserved histidine residue followed by its activation.
Once activated, the phosphate is transferred to an aspartic acid residue of the regulator
initiating a specific response. Each activated regulator has a particular function such as
activation or repression of gene transcription, or modification of proteins affecting their
activity. This entire phosphorelay ultimately leads to a variety of outcomes beneficial
for the bacterium including metabolic adaptation, and control of bacterial virulence or
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other complex developmental processes (sporulation, biofilm formation, and flagellar
assembly and rotation) (28, 87).
Histidine kinases are typically found as homodimers located within the cell
membrane (Figure 3), although, there are also examples of kinases found in the
cytoplasm such as CheA and NtrB (11). There are three important domains that typify
this enzyme. The input or sensing domain located at the N-terminus contains two
transmembrane regions forming a sensor loop that monitors any external changes.
Since each kinase is responsible for sensing a specific environmental stimulus, this
region is highly variable. The central dimerization domain possesses the conserved
histidine residue, which is the site of phosphorylation during activation, and the kinase
domain at the C-terminal end encompasses four conserved boxes (N, D (G1), F, G (G2))
containing key residues important for providing the ATP-binding pocket and allowing for
autophosphorylation. Sequences of the latter two domains have been the basis for
classification of eleven subfamilies of histidine kinases (89). Although phosphorylation
is the primary function of these kinases, many also possess phosphatase activity having
the ability to dephosphorylate activated response regulators (87).
The simplest form of the response regulator includes two major domains: an Nterminal regulatory or receiver domain, and a C-terminal effector domain. A diagram of
the regulatory protein is shown in Figure 3. The regulatory or receiver domain contains
the highly conserved aspartic acid residue, which is phosphorylated by the cognate
sensor kinase upon activation, as well as other important residues needed for the
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Figure 3. Phosphorelay between the cognate sensor kinase and the response
regulator. The histidine kinase located in the inner membrane extends into both the
periplasm and the cytoplasm while the response regulator is located in the cytoplasm.
Both proteins contain important domains and motifs needed for their functions. In the
signaling cascade, an environmental stimulus sensed by the kinase induces the
autophosphorylation of the protein at a conserved histidine residue. The phosphate is
transferred to an aspartic acid residue of the regulator resulting in a response.
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phosphotransfer process. These amino acids, which have been extensively
characterized in CheY, are D12, D13, D57 and K109; the numbers correspond to their
positions found in CheY. The three aspartic acids bind and position a Mg2+ ion that is
required for the transfer of the phosphate to Asp 57. The lysine residue increases the
rate of this process making it more efficient (34, 87). The C-terminal effector domain
has many functions including DNA, RNA, or protein binding, or enzymatic activity, and is
highly variable since there are a number of possible outputs, however, only one is
accomplished for each regulator. A common output is transcriptional regulation and
there are three major subgroups with a helix-turn-helix (HTH) motif in the effector
domains that bind DNA: OmpR/PhoB, NtrC, and FixJ. The NtrC family of regulators
(including NtrC, DctD, PilR, FleQ, and NifA) has a third domain that is not present in
OmpR/PhoB or FixJ, which is a central ATPase domain. This region is important for the
function of these regulatory proteins, which interact with sigma 54 and provide the
necessary energy needed for promoter clearance by this sigma factor (28).

KinB/AlgB, a response regulator and histidine kinase pair in P. aeruginosa
The amino acid sequence of AlgB is homologous to the class of response
regulators in the NtrC family. As stated above, members of this family of regulators are
classified based on the presence of three domains. Figure 4A depicts the AlgB protein,
and illustrates the three domains containing conserved motifs and residues that
characterize the function of these regulators. Aspartic acid residue 59, the site of
phosphorylation, is present in the N-terminal domain. Other important residues located
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within this region are D15, D16, and K109, which correspond to D12, D13, and K109 of
CheY, and have been shown to be necessary for the phosphotransfer process and
activation of these response regulators (12, 84, 87, 91).
The central domain of AlgB contains four conserved motifs that are identical or
nearly identical to NtrC of Klebsiella pneumoniae: the ESELF motif, the GAFTGA loop,
Walker box A (phosphate binding or P-loop), and Walker box B (91). These four sites
have been demonstrated to be important for the function of the regulators belonging to
the NtrC family. The ESELF motif is important in the initial binding of the activator to
the sigma 54 holoenzyme. Alanine substitutions within this region inhibit transcriptional
activation, and chemical cross-linking assays result in the loss of transcriptional activity
from a lack of binding between the activator to sigma 54 and to the β subunit of RNA
polymerase (RNAP) (85, 95). The GAFTGA loop is believed to couple the energy
released by ATP hydrolysis to open complex formation. Both NtrC (57) and DctD (85)
containing mutations within this motif prevent transcriptional activation yet retain their
ability to hydrolyze ATP. Based on these results, the mutations either inhibit direct
contact between the regulators and the sigma 54 holoenzyme and/or prevent the
coupling of ATPase activity to open complex formation. Wang et al. (85) performed
cross-linking assays using the DctD mutants and showed binding to both sigma 54 and
the β subunit of RNA polymerase. Therefore, it was concluded that the GAFTGA motif
is not actually a major sigma 54 holoenzyme binding determinant but that it is
important for harnessing the energy from ATP hydrolysis to open complex formation
(85, 95). Lastly, the two Walker boxes found in the central domain are important for
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ATP binding and hydrolysis. Possession of these two motifs has further classified the
NtrC family of regulators under a larger and functionally diverse group of enzymes
called AAA+ (ATPase associated with various cellular activities) superfamily (31). The
highly conserved Walker box A (GXXXXGKE, X is any amino acid) is a glycine rich region
that interacts specifically with the phosphate groups of ATP by looping around the
β phosphate and coordinating the Mg2+ ion with the β and γ phosphates of ATP (1).
Binding affinity assays reveal a loss of affinity for MgATP following a substitution of the
second glycine within this motif of NtrC compared to wild type (69). The glycine
residue appears to be important for the loop formation around the β phosphate (1) and
this modification may have resulted in the loss of that secondary structure and
consequently the binding of MgATP. Walker box B (hhhhDE, h is a hydrophobic amino
acid) binds and hydrolyzes ATP. The significant residue within this motif determined to
be essential for the hydrolysis of ATP is the aspartic acid, since substitutions of this
amino acid result in no ATPase activity. Interestingly, these mutants are not adversely
affected in their ability to bind MgATP and actually display a ~5 fold higher binding
affinity compared to wild type. Rombel et al. (69) believe that the increase in affinity
results from a decrease in electrostatic repulsion with the loss of the negatively charged
amino acid. Structural data of this motif show that the aspartic acid residue indirectly
coordinates the Mg2+ ion with an intervening water molecule. This coordination is
important because it supports the nucleophilic attack of the phosphorus resulting in the
cleavage of the β-γ bond (39, 69).

19
The C-terminal domain of AlgB contains the helix-turn-helix (HTH) motif needed
for DNA binding. The 20 amino acid sequence contains highly conserved residues
including an alanine or glycine at position 5; a glycine at position 9; and a valine,
leucine or isoleucine at position 15. Generally, hydrophobic amino acids occupy
positions 4, 8, 10, 16, and 18 forming a hydrophobic core within the two helices (32,
91). A basic tri-helical structure is typically seen with the NtrC family of regulators with
the second and third helices representing the 20 amino acid sequence used to define
this motif. Residues 1-7 constitute the second helix while residues 12-20 characterize
the third helix. The intervening sequence between the two helices creates the sharp
turn mediated by the glycine residue at position 9. DNA sequence recognition and
interactions observed between the regulator protein and the major groove of the DNA
backbone is accomplished by the third helix also known as the recognition helix (3).
KinB is the cognate sensor kinase of AlgB (46). The gene coding for the kinase
is immediately downstream of algB in an operon. Sequence alignment of KinB displays
homology to other histidine kinases based on conservation of critical domains and
motifs as shown in Figure 4B. The N-terminus contains two hydrophobic regions
representing transmembrane domains and integration into the inner membrane. PhoA
fusions confirm periplasmic localization of the intervening sequence between the two
domains. Found within the central domain of KinB is the highly conserved histidine
residue (H385) and within the C-terminal domain is the ATP binding site composed of
the four conserved boxes (N, D (G1), F, G (G2)) containing essential amino acids
needed for ATP hydrolysis. Autophosphorylation studies were conducted using

20
radiolabeled ATP, [γ-32P] ATP, to determine whether these conserved motifs are
important for this process. Mutations to H385 as well as critical residues within each of
the conserved boxes inhibit autophosphorylation of KinB supporting the importance of
these residues in the function of the enzyme. Phosphotransfer experiments from KinB
to AlgB were also performed using [γ-32P] ATP. Radiolabeled AlgB is only observed in
the presence of phosphorylated KinB confirming this protein as the cognate sensor
kinase of AlgB (46).

21

Figure 4. Modular structures of AlgB and KinB. A. AlgB is composed of three
major domains: the receiver domain, the ATPase domain, and the DNA binding
domain. Located within each domain are essential motifs and residues characteristic of
the NtrC family of response regulators. The conserved aspartic acid residue, D59, is
the site of phosphorylation and is found in the receiver domain. Within the ATPase
domain are the two Walker boxes for ATP hydrolysis and the sites of sigma 54
interactions, ESELF and GAFTGA. The helix-turn-helix motif is located in the DNA
binding domain, and the amino acids are numbered according to their position within
the motif and not in the polypeptide. The asterisks indicate the amino acids that are
highly conserved in the helix-turn-helix, at positions 5, 9, and 15. B. KinB possesses
three domains: the sensor domain, the dimerization domain, and the kinase domain.
Two hydrophobic regions representing the transmembrane domains (TM) are in the
sensor region. The highly conserved histidine residue is located in the H box found in
the dimerization domain, and the ATP binding region consisting of the N, D, F, and G
boxes are at the kinase domain. The black arrowheads indicate the important residues
within each box.
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Transcriptional activation by NtrC
The NtrC effector was the first of its kind to be discovered and the characteristics
of this enzyme are used to define the family of regulators bearing its name. Extensive
research has been done to understand the mechanism by which this regulator promotes
transcriptional activation. NtrC (nitrogen regulatory protein C) along with its cognate
sensor kinase, NtrB (nitrogen regulatory protein B), are involved in nitrogen
assimilation, and specifically activate the transcription of glnA, glutamine synthetase.
The histidine kinase, located in the cytoplasm, detects levels of nitrogen within the
bacterial cells. Under nitrogen limiting conditions, NtrB undergoes activation via
autophosphorylation at the conserved histidine residue. The phosphate is then
transferred to NtrC dimers resulting in their activation, NtrC-P. These activated dimers
bind to two far upstream enhancer sequences of dyad symmetry in the glnA promoter
at positions –140 and –108 (Figure 5). Phosphorylation of the NtrC dimers is not
required for binding at these two sites and weak cooperative binding has been shown
to occur. However, once the dimers are activated by phosphorylation, there is a strong
increase in the cooperative binding (54). Downstream of the enhancer sites, at
positions –24 and –12, sigma 54 holoenzyme binds in a closed complex formation.
Transcriptional activation can only occur once the NtrC-P dimers oligomerize and
interact with the holoenzyme via DNA looping (62, 78). Hydrolysis of ATP by NtrC-P
provides the energy needed for DNA melting. The ATPase activity is dependent upon
phosphorylation of NtrC and is enhanced in the presence of DNA containing both
binding sites. It is also dependent upon oligomerization of the activated regulators
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Figure 5. Mechanism of transcriptional activation mediated by activated
NtrC. Phosphorylated NtrC dimers (NtrC-P; red dot representing inorganic phosphate)
bind to the glnA promoter at two far upstream enhancer sites (–140 and –108). Also
bound to the promoter is the sigma 54 holoenzyme at positions –24 and –12 in a
closed complex conformation. Activated NtrC-P oligomerizes and bends the promoter
DNA allowing for interactions with sigma 54. The regulator complex then binds and
hydrolyzes ATP releasing energy which is coupled with localized DNA melting around
the +1 site. This allows for open complex formation and promoter clearance by the
holoenzyme resulting in glnA transcription.
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since dimers of NtrC-P in the presence of DNA fragments containing one binding site is
not sufficient for inducing ATP hydrolysis (4, 54). DNA melting subsequently results in
open complex formation around the +1 site allowing for transcription to proceed (34).
The ATPase process is imperative for the formation of open complex since nucleotide
binding alone does not result in transcription. DNAse I footprinting has shown that
once the complex develops, a conformational change also occurs to the sigma factor
resulting in an elongated footprint that extends downstream of the transcriptional start
site (61). Coupling of the energy released by ATP cleavage has been hypothesized to
initiate conformational changes to the transcriptional activator, which causes changes to
sigma 54 and the promoter DNA through interactions with the sigma factor (95).
Multiple studies have been performed to elucidate the oligomerization state of
activated NtrC. Earlier data using scanning electron micrographs observed DNA
fragments containing enhancer sites bound by inactivated and activated NtrC as well as
sigma 54. The images showed activated NtrC-P dimers (~105 kDa) forming complexes
of equivalent size to sigma 54 (~450 kDa) indicating protein interactions of two or more
of these NtrC-P dimers (62, 78). Scanning force microscopy has also been used to
visualize these large multimeric forms but their actual sizes could not be determined.
The information gained from these images has shown that the complexes are larger
than a tetramer, and that the association of the activated dimers build on top of those
already bound to the DNA instead of spreading out along the DNA fragment (68, 93).
Analytical ultracentrifugation studies have been performed to determine the
actual size of the NtrC-P oligomers. The first sedimentation equilibrium analysis looked
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at complexes formed by an overactive mutant of NtrC, NtrCS160F, in the presence of
ATPγS. The results of this assay determined that the higher-order states produced
were either a hexamer or an octomer. The octomer model had a slightly better fit to
the data obtained, however, it was not significantly different compared to the hexamer
model (20). A more extensive study using both sedimentation equilibrium and
sedimentation velocity assays determined that the NtrC-P multimers were octomeric
structures. Molecular weights of complexes formed between NtrC and DNA fragments
carrying either one or two enhancer sites were calculated, and the size of the protein
oligomers could be determined by fixing the molecular weights of the DNA templates.
A simple hydrodynamic model was developed based on the sedimentation velocity data
depicting NtrC dimers as V shaped structures (Figure 6A). The C-terminal DNA binding
domains were located at the bottom of the V and the N-terminal receiver domains at
the top. The octomer was depicted with interactions between different NtrC dimers
occurring between the phosphorylated receiver domains and the central ATPase
domains (66).
Most recently, a 3-D modeling of full-length activated NtrC complex was
determined using imaging data from small- and wide-angle X-ray scattering
(SAXS/WAXS), and electron microscopy. The oligomeric configuration determined was
a hexamer, which was also confirmed by analytical ultracentrifugation analyses, and
differed from the octomeric configuration determined by Rippe et al. The overall
structural model (Figure 6B) depicts a hexameric ring composed of the central ATPase
domains with the receiver domains along the periphery of the ring, and the helix-turn-
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helix DNA binding domains located beneath. Electron microscopy displayed density
differences between the NtrC hexamers attached to ADP-AlFx (ATP hydrolysis transition
analog) and those attached to ADP representing two different bound states of the
activated regulator, transitional and post ATP hydrolysis, respectively. The complexes
attached to ADP were imaged as thin, flat rings bearing six lobes of electron density
around the outer edges defining the receiver domains. The hexamers attached to ADPAlFx were thicker at the center with extra densities located on the top and bottom of the
rings (Figure 6C). These differences indicated conformational changes observed
between the two bound states of activated NtrC. The extra masses seen by the ADPAlFx associated complexes were determined to be GAFTGA loops needed for sigma 54
interactions above the ATPase ring and the helix-turn-helix motifs for DNA binding
below. Based on these data, a scheme was developed illustrating the changes
observed by NtrC during its activation and subsequent association with sigma 54
(Figure 6D). After phosphorylation of the NtrC dimers, each monomer unit is
rearranged so that the receiver domain of one contacts the ATPase domain of the other
ultimately promoting the hexameric ring formation. The hexamer when bound to ATP
in its transitional state of hydrolysis becomes modified resulting in exposure and
arrangement of the GAFTGA loops on top of the ATPase ring allowing for interaction
with sigma 54. On the bottom of the ring structure, the helix-turn-helix domains bind
to the enhancer sites with some distortion. Once ATP hydrolysis occurs, the GAFTGA
loops become disordered and sigma 54 association is lost. The hexamer ring is also no
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longer connected to the DNA because it is believed that the DNA binding domains
become flexible and detach from the central ATPase ring (15).
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Figure 6. Oligomerization models of activated NtrC. A. Hydrodynamic model of
NtrC dimers (red spheres) bound to DNA fragments (blue spheres) with either one (top
left) or two (top right) enhancer sites. For NtrC, each of the red spheres represents
domains of the proteins: receiver domain, linker region, ATPase domain, and DNA
binding domain. Multimerization of four activated dimers bound to DNA with two
enhancer sites (bottom). The yellow and red spots indicate phosphorylation of NtrC
dimers. Protein-protein interactions are shown with two dimers bound to the DNA (red)
interacting with two other dimers (yellow) in an octomeric formation. Reprinted with
permission from Journal of Molecular Biology. B. Structural model of activated NtrC
based on data from SAXS/WAXS displaying a hexameric complex with the receiver
domain (orange), ATPase domain (white), and DNA binding domain (cyan). C. EM
images showing density changes of the NtrC hexamer bound to ADP-AlFx (analog of
ATP hydrolysis transition state) compared to those bound to ADP. The complexes
bound to ADP-AlFx showed densities above and below the ATPase ring representing the
GAFTGA loops and the helix-turn-helix motifs, respectively. These are absent when
bound to ADP. D. Mechanism of NtrC reconstruction mediated by its activation
ultimately resulting in transcriptional activation. The receiver (R), central or ATPase
(C), and DNA binding (D) domains are shown in the diagram as well as sigma 54 (σ54)
and the GAFTGA loops. Reprinted with permission from Genes and Development.
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Overactive response regulators
There are limitations to studying activated response regulators including their
dependence for phosphorylation by the cognate sensor kinases which must initially be
activated by autophosphorylation, and their intrinsic rate of dephosphorylation resulting
in a mixture of both the active and inactive forms (34). These limitations have hindered
researchers from further comprehending the properties of these proteins upon
activation. An important and useful tool discovered to overcome the restrictions as well
as to facilitate a better understanding of the characteristics of these regulators is an
overactive mutant form. These overactive proteins not only have the ability to
hydrolyze ATP and to activate transcription independent of phosphorylation, they also
provide a homogeneous population. Two regulators that have been investigated using
these mutant forms are NtrC and DctD.
There have been a number of studies performed to observe the mutant forms of
NtrC independent of phosphorylation for transcriptional activation (18, 24, 61, 62, 86).
Flashner et al. (24) searched for overactive NtrC proteins from Salmonellla typhimurium
by selecting for either spontaneous or chemically mutagenized strains that were able to
suppress null alleles in ntrB. They found that the suppressor mutations are located in
two domains of the regulator, the N-terminal receiver domain, and the central catalytic
domain. The most active of the overactive mutant is NtrCS160F having the highest level
of both ATPase and transcriptional activities (24). The NtrC regulators from different
bacterial strains carrying this specific amino acid substitution have been previously
observed to show similar levels of transcriptional activity as Salmonella (18, 86). This
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overactive mutant has aided researchers to discover more properties of the activated
protein. They were able to determine that oligomerization of the NtrC regulator is
important for ATP hydrolysis because an over abundance of enhancer binding sites
prevent ATPase activity of the mutant protein. This decrease in hydrolysis is believed to
be a result of a widespread distribution of activated regulators to different DNA
molecules as dimers preventing protein aggregation (62). Utilization of NtrCS160F
mutant protein has also allowed researchers to identify the location of the
oligomerization determinants to be within the central activation domain of the protein.
It has been known for some time that in order for transcriptional activation to occur,
dimers of phosphorylated NtrC must form oligomers. There was speculation that the Nterminal region is responsible for this process since its removal renders the regulator
inactive. However, three lines of evidence were observed to support the central domain
as the site for oligomerization. Firstly, a derivative of NtrCS160F containing an N-terminal
deletion (ΔN-NtrCS160F) retained its ability to activate transcription contrary to wild type
and therefore its ability to multimerize correctly. This is evidence that the
oligomerization determinants exist outside of the N-terminal domain. Secondly, the ΔNNtrCS160F maintained its ATPase activity and therefore its ability to aggregate. As
mentioned previously, the full-length overactive mutant has provided evidence of ATP
cleavage to be dependent upon oligomerization. Furthermore, as shown with fulllength NtrCS160F, the deleted N-terminal form displayed a decrease in ATP hydrolysis
when combined with an excess of enhancer binding sites, again, presumably due to a
distribution of proteins as dimers to the extra DNA molecules. Finally, the ΔN-NtrCS160F
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mutant combined with a non DNA-binding form, NtrCS160F,3ala, synergistically activated
transcription. This synergy is believed to be a result of protein-protein interactions once
the N-terminal mutant form binds to the DNA binding site. These results clearly show
that oligomerization is not dependent on the N-terminal domain. Based on previous
studies the multimerization process is also not dependent on the C-terminus since
protein-protein interactions do not occur with this domain (62). Therefore, it has been
concluded that the oligomerization determinants lie within the central domain of the
NtrC regulator (24).
C4-dicarboxylic acid transport D (DctD) is a response regulator found in
rhizobium, a soil bacterium. DctD with its cognate sensor kinase, DctB, regulate the
transcription of DctA, a membrane transport protein for the uptake of C4-dicarboxylates,
such as succinate, fumarate, and malate. The rhizobia utilize these compounds for
energy under free-living conditions or for nitrogen fixing as endosymbionts of
leguminous plants. Although DctA is required for both living conditions, the twocomponent system (DctB/DctD) is only involved in regulating the transport protein
when the bacterium is free-living. DctB senses the presence of these carbon sources
and initiates the phosphorelay cascade upon detection resulting in the activation of
DctA transcription via DctD (94). Contrary to NtrC, one of the initial overactive forms of
DctD discovered is a mutant with the removal of the first 142 amino acids representing
the N-terminal domain, DCTDL143. This discovery led researchers to conclude that the
function of the N-terminus is different for each regulator. For NtrC, phosphorylation is
needed to allow for transcriptional activation, and for DctD, phosphorylation removes
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the inhibition for transcriptional activation. The truncated form of DctD displays
transcriptional activity as well as ATP hydrolysis independent of phosphorylation. As
with the overactive NtrC mutant, protein concentrations of DCTDL143 have an effect on
the amount of ATPase activity and the amount of dctA transcript, suggesting the need
for the formation of a higher order complex. It was also determined that the truncated
regulators bind the dctA upstream activation sequences (UAS) with increased
cooperativity compared to wild type (41, 72). Meyer et al. (55) generated multiple
DctD overactive mutants to obtain a better understanding of the mechanism involved in
the negative regulation exhibited by the receiver domain. The researchers first
determined the homodimer interactions between the regulator proteins and found that
not only are there N-terminal secondary structures involved but also the linker region
between the receiver and central domains. They looked further to define the regulatory
role of the dimerization determinants by randomly mutating full-length DctD and
selecting proteins that are overactive for ATPase and transcriptional activity. The
overactive mutants that were identified map to regions within or directly under the
dimer interface resulting in dimer destabilization and active protein. Based on these
data, a simple model is proposed illustrating two dimeric conformations, one that is
active and the other that is inactive. The inactive form becomes active by
phosphorylation, which destabilizes the dimerization surface and allows the central
domain to be functional.
The discovery of overactive mutants has been one of the most useful and
important tools for studying and understanding response regulators. These mutants
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help to provide researchers with not only an active protein for transcription and ATP
hydrolysis but also a stable protein preventing a mixture of inactive and active forms. A
homogenous population of overactive proteins has made it easier for scientists to
investigate the properties of activated regulators without having to mimic the
complicated phosphorelay process. This has provided insight into the oligomerization
and dimerization determinants of NtrC and DctD, which has led to an understanding of
the functional properties of these regulators.

Research objectives
Alginate regulation has been studied extensively and AlgB has been shown to be
important for its copious production (29). Once this activator was established as a
member of the NtrC family of response regulators (91) and demonstrated to be
phosphorylated by its sensor kinase, KinB, (46) research was done to determine
whether two-component regulation is involved in alginate activation. Mutants were
generated preventing phosphorylation of AlgB, which included an N-terminal deletion
(Δ1-145) and a site-directed mutation (D59N) of AlgB, and a null mutation
(kinB::Tn501) of KinB. All three were integrated into the chromosome of an alginate
producing strain, FRD1 (mucA22). None of the mutations inhibit the mucoid phenotype
arguing against the need for AlgB phosphorylation and two-component signaling in the
production of alginate (45). Subsequent research has not been done to further the
understanding of AlgB and KinB as a two-component system. The goal of this research
dissertation is to better characterize the KinB/AlgB regulon specifically studying the role
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of AlgB in this mechanism of regulation. First I identified an overactive variant of AlgB
that induced alginate biosynthesis in P. aeruginosa. Next, I determined the sigma
factor involved in the transcriptional activation of the algD operon. I then explored the
possible mechanisms responsible for the overactivity induced by the mutant AlgB, and
lastly, I investigated additional promoters under AlgB control.

Chapter 2: Materials and Methods

Bacterial strains and cultivation
A list of Pseudomonas aeruginosa and Escherichia coli strains used in this study
is found in Table 1. All of the genetic manipulations performed throughout this study
were done using the wild type P. aeruginosa strain, PAO1, a non-alginate producing
burn wound isolate. E. coli strains, DH5α and MC1061, were used for routine cloning.
All bacteria were maintained in Luria-Bertani (LB) broth (10 g tryptone; 5.0 g yeast
extract; and 5.0 g NaCl per liter, pH 7.5) and on LB agar (Fisher). P. aeruginosa was
also grown and maintained on a solid medium called 1/2 PIA containing half LB agar
and half Pseudomonas Isolation Agar (PIA, Difco). Additionally, this medium was used
as a counterselection against E. coli following triparental mating because PIA contains
an antibiotic, triclosan, that is not active against Pseudomonas. For electroporation of

P. aeruginosa strains, cells were recovered in 1 mL SOC broth containing 20 g of
tryptone; 5 g of yeast extract; 3.6 g of glucose; 10 mM NaCl; 2.5 mM KCl; 10 mM
MgCl2; and 10 mM MgSO4 per liter, pH 7.5. Selective antibiotics used for P. aeruginosa
included carbenicillin at 100 µg/mL and gentamicin at 100 µg/mL. Those used for E.

coli were ampicillin at 100 µg/mL, kanamycin at 30 µg/mL, and gentamicin at 15
µg/mL.
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Chemically competent E. coli strains

Escherichia coli strains used for propagating plasmid constructs included DH5α
and MC1061. These were made chemically competent with exposure to CaCl2 and
MgCl2. Overnight cultures of each strain were diluted 1:100 in LB broth and grown to
an OD600 of 0.6. Cells were harvested by centrifugation at 10,000 rpm for 10 min
(4˚C), and pellets were resuspended with 0.1 volume of ice cold Solution A (80 mM
CaCl2 and 50 mM MgCl2). These were incubated on ice for 10 min, harvested, and
incubated again with Solution A. The cells were centrifuged and the pellets were
resuspended with 0.06 volume of ice cold Solution B (100 mM CaCl2) and 0.06 volume
of 50% glycerol. The suspension was aliquoted to microfuge tubes, and stored at
–80˚C.
For transformation of these chemically competent E. coli strains, 100 µL of cells
were combined with 10 µL of plasmid, and incubated on ice for 45 min. The mixture
was heat shocked at 42˚C for 40 seconds, immediately transferred to 1 mL of
prewarmed LB broth, and incubated with a shaking incubator at 37˚C for 1 hour. The
transformants were spread onto selective media and incubated overnight at 37˚C.
Quick-check method. This assay was used to screen a large number of
transformed E. coli candidates by visualizing individual plasmids potentially containing
the cloned inserts and selecting candidates carrying the desired constructs based on
size. The protocol used was previously designed and followed as published (2).
Overnight LB broth culture with antibiotic selection was prepared for each possible E.

coli candidate. In microfuge tubes, 50 µL of phenol/chloroform (1:1) and 10 µL of
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loading dye (40% glycerol and bromophenol blue) were aliquoted. One hundred
microliters of each overnight culture were added to the appropriate tubes and vortexed.
The mixture was microcentrifuged at 14,000 rpm for 3 min, and 20 µL of the
supernatant were loaded onto a 0.7% agarose gel. A supercoiled ladder was used to
determine the size of the constructs, which were generally located between a
chromosomal DNA band at the top and three RNA bands at the bottom of the gel.

Triparental conjugation of plasmids into P. aeruginosa strains
This process involved the combination of three bacterial strains: a donor (E. coli),
helper (E. coli), and recipient (P. aeruginosa) strain. The constructs carried by the
donor were moved into Pseudomonas with the assistance of a helper strain carrying
pRK2013 (23), a conjugative plasmid containing tra+ genes needed for transfer. The
three strains were grown separately overnight in LB broth with or without antibiotic
selection. The donor and helper overnight cultures were diluted in LB broth (1:100)
and grown for 4 hours at 37˚C shaking. One mL of recipient overnight was added to 1
mL of LB broth with 40 µL of 1 M NaNO3 (20 mM final). The addition of NaNO3 to the
medium was necessary to reduce the DNA restriction modification system of

Pseudomonas. This was incubated static for 4 hours at 37˚C. After 4 hours of
incubation, the three strains were combined: 600 µL of donor, 600 µL of helper, and
200 µL of recipient. The cell mixture was pelleted at 13,000 rpm for 3 min in a
microcentrifuge, and the pellet was washed once with 500 µL of sterile saline. The cells
were subsequently resuspended with 40 µL of saline and spotted onto the middle of an
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LB agar plate. The plate was incubated upright overnight at 30˚C. The next day, the
conjugation spot was collected using a sterile swab and resuspended in 3 mL of sterile
saline. The suspension was spread plated onto 1/2 PIA with antibiotic selection and
grown overnight at 37˚C.

Electroporation of plasmids into P. aeruginosa strains
Prior to electroporation, electrocompetent Pseudomonas strains were prepared.
An overnight culture of Pseudomonas was diluted in LB broth (1:79) and grown to an
OD600 between 0.5-0.8. The entire culture was centrifuged for 20 min at 4,000 xg
(4˚C), and washed three times with 2 mL of 0.3 M sterile sucrose (25˚C). Between
each wash step, the suspension was centrifuged for 20 min at 4,000 xg (25˚C). The
final pellet was resuspended with 0.2 mL of 0.3 M sucrose, aliquoted in 40 µL to
eppendorf tubes, and stored at -80˚C.
For the electroporation assay, 40 µL of electrocompetent Pseudomonas cells
were thawed on ice and combined with 5 µL of plasmid construct. This mixture was
transferred to a 0.2 cm cuvette (Fisher) that had been prechilled on ice. The cells were
electroporated using the Gene Pulser and Pulse Controller system from BioRad with the
following settings: 1.6 kV, 25 µF, and 200 Ω. The electroporated cells were added to 1
mL of ice cold SOC broth, and was incubated for one hour at 37˚C shaking to allow for
recovery. The recovered cells were spread onto 1/2 PIA plates with antibiotic selection.
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Construction of PAO ΔalgB-kinB mutant strain
Regions 1 kb upstream and downstream of the algB-kinB operon were amplified
in two separate PCR reactions using primers, upalgBf and upalgBr, and primers,
downkinBf and downkinBr, respectively (Table 1). The two products were ligated
together via a BamHI site that had been added to the two internal primers. This 2 kb
fragment was used as a template for a third PCR reaction using the forward (upalgBf)
and reverse (downkinBr) primers of the upstream and downstream regions,
respectively. The insert was gel purified with the QIAEXII kit (Qiagen) and cloned in
blunt ended into the SmaI site of a suicide vector, pEX100T (74) resulting in pJHK11.
Chemically competent E. coli strain DH5α were transformed with the new construct and
selected for amipicillin resistance. Candidates were screened using the quick-check
method to determine which of these carried the construct with the 2 kb insert.
Triparental conjugation was performed to move pJHK11 into PDO401 (PAO

algB::Gm) using a helper strain carrying pRK2013, which contains the transfer functions
needed for mobilization. Merodiploid clones incorporating the entire plasmid into the
genome were selected using plates of 1/2 PIA with carbenicillin (100 µg/mL). These
candidates were pooled and grown overnight in 10 mL of LB broth. The overnight was
spread onto 1/2 PIA plates containing 6% sucrose to prompt a double crossover event
removing the algB-kinB operon as well as the vector. Colonies that grew on the
sucrose plates were patched onto 1/2 PIA plates including one of the following: 6%
sucrose, carbenicillin (100 µg/mL), or gentamicin (100 µg/mL). Candidates that were
chosen grew in the presence of sucrose but were sensitive to both antibiotics. These
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were designated as JK159. The deletion of the algB-kinB operon from these candidates
was further verified by PCR amplification of the algB gene using primers algBf and
algBr.

Site-directed mutagenesis of algB
Crossover PCR was performed to generate mutations within algB from the

Pseudomonas strain, PAO1. The oligonucleotides used for this process are listed in
Table 1. Four primers were created for each algB mutation with two internal
overlapping primers and two external primers to encompass the entire algB gene. The
forward and reverse internal primers, HisAlgB2, HisAlgB3, and HisAlgB4, were designed
to carry the site-specific mutations, which included D105K, E125K, and R442E,
respectively. The forward (HisAlgB1f) and reverse (HisAlgB1r) external primers
incorporated a BamHI site and a HindIII site, respectively. The upstream and
downstream regions of the algB gene containing the site-specific mutation were PCR
amplified in two separate reactions. For the R442E mutation, these regions were
amplified using pJHK13 as a template. Since the nucleotides changed within the helixturn-helix motif were close to the end of the algB gene, an alternate reverse external
primer, pTrcHisAr, which incorporated part of the pTrcHisA vector, was used. A third
crossover PCR reaction was prepared using all of these upstream and downstream
regions as template and the external primers, HisAlgB1f and HisAlgB1r, to generate a
full length algB (1.35 kb) fragment. Wild type algB was also PCR amplified using these
same external primers. The mutated as well as wild type genes were sequentially
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digested with BamHI and HindIII. Following each PCR reaction and digestion, the DNA
fragments were gel purified using the QIAEXII kit. These fragments were cloned into
pUC19 and generated constructs pJHK14 (wild type AlgB), pJHK15 (AlgBD105K), pJHK16
(AlgBE125K), and pJHK22 (AlgBR442E). These constructs were used to transform
chemically competent DH5α cells and the candidates were screened via the quick-check
method. The QIAprep spin miniprep kit (Qiagen) was used to harvest the desired
plasmids from the E. coli cells following protocol as specified by the manufacturer.
These were all outsourced to Eurofins MWG Operon for DNA sequencing using M13
primers both in the forward and reverse directions.

Construction of His-tagged AlgB constructs
In order to construct His-tagged AlgB proteins, the wild type and mutant algB
genes were sequentially digested out of pJHK14, 15, 16, and 22 with BamHI and

HindIII. The 1.35 kb inserts were gel purified using the QIAEXII kit after each
digestion. These were cloned into the same sites of the pTrcHisA (Invitrogen) vector,
which incorporates six histidine residues to the N-terminus of the AlgB proteins. The
resulting constructs were pJHK12 (His-AlgBwt), pJHK17 (His-AlgBD105K), pJHK18 (HisAlgBE125K), and pJHK23 (His-AlgBR442E), and were used to transform chemically
competent DH5α cells. Candidates were selected on LB agar with ampicillin (100
µg/mL) and the quick-check method was used to screen colonies carrying the desired
plasmid. Since the pTrcHisA base vector lacked the stabilizing fragment (mSF; 1.2 kb)
for autonomous replication in Pseudomonas, this fragment was digested out of pSS124
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with SphI, gel purified with the QIAEXII kit, and ligated into the SphI site of pJHK12,
17, 18, and 23 generating pJHK13, 19, 20, and 28, respectively. The new constructs
were used to transform chemically competent E. coli MC1061 and candidates were
selected on LB agar with ampicillin (100 µg/mL). The quick-check method was used to
determine the clones with the desired mSF (1.2 kb) insert. Since the base vector also
lacked an oriT, which is needed for vector mobilization via conjugation, each construct
was electroporated into strains JK159, JK215, JK231, and PDO402. The electroporated
cells carrying the constructs were selected by spreading onto 1/2 PIA plates with
carbenicillin (100 µg/mL).
A His-tagged AlgB N-terminal deletion mutant was also constructed. Inverse PCR
was performed using pJHK13 as a template. Primers, HisAlgB5f and HisAlgB5r (Table
1), were designed excluding 438 bp of the algB gene representing the first 145 amino
acids. The 6.5 kb product was gel purified as outlined by the QIAquick gel extraction
kit (Qiagen) and ligated together forming pJHK26. The construct was transformed into
chemically competent E. coli strain MC1061 and PCR amplifications were performed
using primers to the entire algB gene (algBf and algBr) and the shortened algB gene
(HisAlgB5f and algBr) for verification. Primers are listed in Table 1. Verified construct
was isolated from MC1061 via the QIAprep spin miniprep kit (Qiagen) following
manufacturer’s protocol, and electroporated into JK159. Candidates were selected on
1/2 PIA with carbenicillin (100 µg/mL).
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Mutagenesis of sigma factor genes in the chromosome
Sigma 22. This mutation was moved from an available lab strain, PAO

algT::Gm, to JK159 via generalized transduction with phage F116L. F116L phage
lysates of PAO algT::Gm were generated using a previous phage stock. The stock was
10 fold serially diluted in 7 tubes with each tube containing 90 µL of LB broth and the
first tube containing 10 µL of phage stock. A culture of PAO algT::Gm was grown
overnight in the presence of 10 mM MgCl2 and 5 mM CaCl2. Two hundred microliters of
this culture were added to each of the 7 tubes of diluted phage. These were incubated
at room temperature for 10 min to allow for adsorption. LB top agar (0.7% agar)
containing 10 mM MgCl2 and 5 mM CaCl2 was placed in a 50-55˚C water bath to keep
the medium molten. Three milliliters of the top agar were added to the adsorption,
vortexed, and poured onto the top of LB agar plates. The plates were tilted back and
forth to evenly spread the soft agar. Once the top agar solidified, the plates were
incubated upright overnight at 37˚C.
Bacteriophage was harvested from the dilution plate that exhibited confluent
lysis (i.e. plaques still defined), which was dilution plate 4. Three milliliters of LB broth
were added to the top of the agar and the plate sat at room temperature to soften the
top agar. A sterile spreader was used to gently scrape up the soft agar layer. This was
transferred to a sterile test tube, vortexed, and placed at 4˚C for 1 hour. The lysate
was centrifuged at 7,600 xg for 10 min at 4˚C to pellet the agar and bacterial cell
debris. The supernatant was collected, and filter sterilized to remove any remaining
cellular contaminants. This was stored at 4˚C.
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Transduction was performed using the F116L lysate of PAO algT::Gm prepared
above. One milliliter of JK159 overnight culture was combined with 100 µL of lysate
and left at room temperature for 20 min to allow for adsorption. This was transferred
to 3 mL of LB broth, incubated for 1 hour at 37˚C, and spread onto 1/2 PIA with
gentamicin (100 µg/mL). Candidates grown on the plates were further verified via PCR
using primers, algTf and algTr (Table 1). These candidate strains were labeled JK215
(PAO ΔalgB-kinB algT::Gm).
Sigma 54. PCR amplification of rpoN was performed using primers (rpoNf and
rpoNr) listed in Table 1. The amplicon (1.5 kb) was gel purified using the QIAquick gel
extraction kit and cloned into the SmaI site of pEX100T producing pJHK24. Chemically
competent DH5α cells were transformed with these constructs and selected for
ampicillin resistance. The quick-check method was used to screen for clones containing
the desired plasmid. The gentamicin cassette (aacCI; 900 bp) digested out of pUCGM1
(73) using PstI was gel purified with the Qiaquick gel extraction kit, and cloned into the
unique PstI site of pJHK24 located within rpoN. This plasmid, pJHK25, was used to
transform chemically competent MC1061, which were selected for ampicillin resistance
and screened using the quick-check method. A triparental conjugation was performed
to mobilize pJHK25 into strains PAO1 and JK159. Merodiploids were selected by spread
plating onto 1/2 PIA with carbenicillin (100 µg/mL). These were pooled and used to
inoculate 10 mL of LB broth. The culture was incubated shaking overnight at 37˚C.
They were spread onto 1/2 PIA containing 6% sucrose and gentamicin (100 µg/mL) to
select for double recombinants. Clones were patched onto 1/2 PIA with carbenicillin
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(100 µg/mL) and 1/2 PIA with gentamicin (100 µg/mL) to ensure that candidates were
sensitive to the former antibiotic and resistant to the latter. They were also verified by
PCR using rpoN primers (rpoNf and rpoNr) listed in Table 1. The mutants produced
were called JK229 (PAO rpoN::Gm) and JK231 (PAO ΔalgB-kinB rpoN::Gm).
The sigma 54 mutation from JK229 was also moved into PDO300 via generalized
phage transduction. Initial phage transduction experiments and multiple attempts at
conjugation were unsuccessful. In order for this new transduction to occur, wild type

rpoN was first introduced into strain JK229 in trans, so that F116L phage lysates could
be generated from this strain. It was necessary to add a functional sigma factor to
complement the rpoN mutation because the phage requires pili for adsorption, which is
dependent upon RpoN. This was the reason for the initial failed attempts at phage
transduction; no lysates could be generated on JK229. PCR amplification of rpoN was
generated using primers (HisRpoN2f and HisRpoN1r) (Table 1) with the forward and
reverse oligos containing an EcoRI and HindIII site, respectively. This fragment was
cloned into pJHK21 at these sites creating pJHK30 and was electroporated into JK229.
F116L lysates were generated as previously described and dilution plates 6 and 7,
displaying confluent lysis, were combined to harvest phage. This lysate was used to
transduce PDO300 and transductants were selected on 1/2 PIA with gentamicin (100
µg/mL). Candidates were labeled JK260 (PDO300 rpoN::Gm), and were verified by PCR
using primers, rpoNf and rpoNr, found in Table 1.
Twitching motility assay. In order to confirm the loss of sigma 54 function
after the insertion of the gentamicin cassette, a twitching motility assay was performed
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using a protocol by McMichael (53). LB agar containing only 1% agar (Difco) was
poured to an average depth of 3 mm into culture plates. A needle was used to
inoculate the mutant and control strains by stabbing through the soft agar to the
bottom of the polystyrene plate. This was incubated overnight at 37˚C, and the zone
of mobility was observed by coomassie staining. Before staining, the LB agar was dried
using a round piece of Whatman no. 1 filter paper, which was placed directly on top of
the agar. Layers of paper towels were put on top of the filter paper and a weight was
added to allow for close contact as well as even and efficient wicking of moisture. Once
the agar became a thin film, it was flooded with coomassie stain (0.25% (w/v)
coomassie brilliant blue R250, 50% (v/v) methanol, and 10% (v/v) acetic acid) and
incubated for 1 min at room temperature. The plate was then washed multiple times
with destain (50% (v/v) methanol and 10% (v/v) acetic acid), and dried at 65˚C for 5
min for permanent storage.

Uronic acid assay
Uronic acids, monomer subunits of alginate, were first isolated from each

Pseudomonas strain via ethanol precipitation. P. aeruginosa strains with or without
plasmids were grown overnight in 10 mL of LB broth in the presence or absence of
antibiotic selection. These cultures were centrifuged for 1 hour at 10,000 xg (4˚C) to
pellet the cells. The supernatants were transferred to fresh centrifuge tubes and 20 mL
of ice cold 95% ethanol were added to each in order to precipitate the uronic acids.
The cell pellets were saved and weighed to determine wet cell pellet weight. The
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precipitated uronic acids were centrifuged for 20 min at 10,000 xg (4˚C) and the pellets
were resuspended in 2 mL of ultrapure water. The suspensions were transferred to
tubes and incubated overnight at 37˚C to allow for complete dissolution.
The precipitated uronic acids were quantitated using the carbazole-borate assay,
based on a protocol by Knutson and Jeanes (38). A standard curve was generated
using sodium alginate (Sigma) produced by Macrocystis pyrifera. A stock solution of
the sodium alginate (2 mg/mL) was diluted using saline to produce final concentrations
of 10, 20, 30, 40, 50, 60, 80, and 100 µg/mL. A borate stock (24.74 g H3BO3 and 45
mL of 4 M KOH per 100 mL) was used to freshly prepare a sulphuric acid-borate
reagent (1:40 borate stock to concentrated H2SO4). One milliliter of the sulphuric acidborate reagent was added to test tubes on ice and 100 µL of dissolved uronic acid
sample or diluted sodium alginate standard was layered on top. The tubes were
vortexed and placed back on ice. Thirty-three microliters of carbazole reagent (0.1%
(w/v) in 95% EtOH) was added. Again the tubes were vortexed and put back on ice.
They were then transferred to a 55˚C water bath and incubated for 30 min. The
reactions were cooled on ice and read on the spectrophotometer at an OD of 530. The
amount of uronic acid for each sample was determined using the standard curve and
normalized against wet cell pellet weight. The alginate assay was done in triplicate for
each strain and the data was graphed as average alginate (µg)/cell pellet (g). A
student’s t-test determined significance compared to PAO1.
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RT PCR and Real time RT PCR
RNA extraction. Total RNA was isolated from subcultures of P. aeruginosa
strains (1:100) grown to late log phase and was accomplished using either the Trizol
reagent (Invitrogen) or the RNeasy mini kit (Qiagen). Both protocols were followed as
outlined by the manufacturers. The RNA was eluted in 30 µL of RNase free water and
contaminating DNA was removed with the DNA free kit (Ambion).
The quality and quantity of RNA isolated was accessed by RNA gel
electrophoresis and by spectrophotometry. For gel electrophoresis, a 1.2% FA gel (1.2
g of agarose, 10 mL 10x FA gel buffer [200 mM MOPs; 50 mM sodium acetate; and 10
mM EDTA, pH 7.0 with NaOH], and 1.8 mL of 37% [12.3 M] formaldehyde in 100 mL)
was cast. A 1x FA gel running buffer (100 mL 10x FA gel buffer and 20 mL of 37%
formaldehyde per liter) and 5x RNA loading buffer (500 mM EDTA [pH 7.0], 720 µL of
37% formaldehyde, 20% (v/v) glycerol, 3084 µL of formamide, and 4 mL of 10x FA gel
buffer per 10 mL) were prepared. RNA samples were combined with 5x RNA loading
buffer and ethidium bromide (1 mg/mL stock) and ran at 5-7 V/cm. The 23S and 16S
rRNA bands were observed to determine the integrity of the total RNA. Samples were
also diluted 1:50 and read in the spectrophotometer at 260 and 280 nm. The quality of
the RNA was accessed based on the 260/280 ratio with a value between 1.8-2.0
representing pure RNA. Quantification was determined using the 260 nm value and the
equation:
RNA (µg/mL) = Dilution factor x 40 µg/mL x OD260
Dilution factor = 50
40 µg/mL = amount of RNA to give an OD260 of 1
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OD260 = absorbance of sample RNA
Reverse transcription. A total of 1 µg of sample RNA was converted to singlestranded cDNA using the Taqman® reverse transcription kit (Applied Biosystems).
Gene specific reverse primers (500 nM) to the internal control gene (omlA; omlARTr)
and the target gene (algD; algDRT3r) found in Table 1 were used. The reactions were
50 µL and contained 1X TaqMan RT buffer, 5.5 mM of MgCl2, 0.5 mM per dNTP, 0.4
U/µL RNase inhibitor, and 1.25 U/µL reverse transcriptase. The reactions were put into
a thermal cycler and incubated at 25°C for 10 min, 48°C for 30 min, and 95°C for 5 min.
PCR. In order to visualize the relative amount of transcripts for each strain, 2 µL
of cDNA were used in a regular PCR reaction. AmpliTaq polymerase (Invitrogen) was
used for the amplification process and the following parameters were set on the
thermal cylcer: 95°C for 2 min; 95°C for 30 sec; repeated for 30 cycles: 95°C for 30 sec,
55°C (for omlA) or 63.3°C (for algD) for 30 sec, and 72°C for 30 sec; 72°C for 7 min;
and 4°C. Equal volumes of PCR products were loaded and run on a 1% agarose gel.
SYBR green assay. The SensiMixPlus SYBR kit (Quantace) containing a 2X
concentrated mix (reaction buffer, heat-activated DNA polymerase, dNTPs, 6 mM MgCl2,
and SYBR Green I fluorescence) was used to determine the amount of specific
transcript in each sample. Initially, primer efficiencies for both omlA and algD were
determined using a 2 fold serial dilution of gene specific cDNA from strain PDO300 and
an annealing temperature gradient from 55°C to 65°C. These were loaded into the
wells of an iQ 96-well PCR plate (BioRad) and the fluorescence was detected and
recorded using the iQ5 detection system (BioRad). The cycle threshold (Ct) values for
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each gene at each temperature were graphed against the log [cDNA concentration
values]. The percent efficiencies were determined using the slope and the equation:
%Efficiency = (10-1/slope) x 100
Annealing temperatures providing efficiencies between 80-100% were chosen for each
gene, which were 55°C for omlA and 63.3°C for algD.
For the qRT PCR reactions, each 25 µL volume included 12.5 µL of 2X SYBR mix
combined with 2 µL of gene specific cDNA along with the forward and reverse primers
(400 nM) of omlA (omlARTf and omlARTr), and algD (algDRT3f and algDRT3r) genes.
The cycling parameters used were as follows: one denaturation cycle at 95°C for 3 min
and 40 amplification cycles consisting of denaturing at 95°C for 10 sec, annealing at
55°C (omlA) or 63.3°C (algD) for 30 sec, and extending at 72°C for 15 sec. Fluorescent
readings were taken after each extension step of a cycle. This was followed by a melt
curve analysis with a temperature range of 55-95°C. Ct values obtained by the
detection system were used to determine relative transcript amounts. For each strain,
the algD (target gene) Ct results were normalized against omlA (internal control gene)
Ct results. An average normalized algD value for each strain was determined, since
total RNA was harvested in triplicate. Average fold changes were graphed comparing
average normalized algD values of the P. aeruginosa mutant strains to wild type PAO1.
A student’s t-test was performed to determine whether fold changes observed were
significant.
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Polyacrylamide gel electrophoresis (PAGE) and Western blot analysis
SDS-PAGE. His-AlgB proteins either purified or within lysates of E. coli or P.

aeruginosa were separated by polyacrylamide gel electrophoresis. Cell lysates were
prepared by determining the OD600 of 1 mL of sample culture, which was pelleted, and
resuspended in 2X sample buffer (125 mM Tris-HCl, pH 6.8; 20% (v/v) glycerol; 4%
(w/v) SDS; 2% (v/v) β-mercaptoethanol; and bromophenol blue) adding 150 µL of
buffer per OD600 of 1. Purified protein was also combined with 2X sample buffer in a
1:1 ratio. All samples were boiled for 5 min before loading onto either a precast 12.5%
polyacrylamide gel (BioRad) or a homemade 12% polyacrylamide gel. The latter was
made with a bottom separating gel (375 mM Tris-HCl, pH 8.8; 0.1% (w/v) SDS; 0.4%
(v/v) 30% liquid acrylamide stock; 250 µL 10% ammonium persulfate (APS) stock; and
10 µL of TEMED in 35 mL) and a top stacking gel (125 mM Tris-HCl, pH 6.8; 0.1%
(w/v) SDS; 0.13% (v/v) 30% liquid acrylamide stock; 200 µL 10% APS stock; and 10
µL TEMED in 15 mL). The gels were electrophoresed in a 1X Tris-glycine buffer (5X
stock; 15.1 g Tris-base, 94 g glycine, and 5 g SDS per 1 liter) at 100 V, and the proteins
were visualized by either coomassie staining or by Western blot analysis. For the
former, the polyacrylamide gels were incubated with coomassie stain (0.25% (w/v)
coomassie brilliant blue R250, 50% (v/v) methanol, and 10% (v/v) acetic acid) for 1
hour at 25°C rocking. Subsequently, the stain was discarded and the gel was washed
multiple times for 15 min with destain (50% (v/v) methanol and 10% (v/v) acetic acid)
and eventually left to destain overnight. The gel was reconstituted in dH2O and dried
for long-term preservation.
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For Western blot analysis, the proteins in the polyacrylamide gels were
transferred onto polyvinylidene fluoride (PVDF) membranes. Ice cold transfer buffer
containing 100 mL of 8X stock (23.28 g Tris-base, and 115.2 g glycine per liter)
combined with 200 mL methanol per liter was used and the transfer electrophoresis
occurred at 100 V for approximately 2 hours. The membranes were blocked overnight
at 4°C rocking with a blocking buffer (1X Tris-buffered saline [100 mM Tris-HCl and 150
mM NaCl, pH 7.5]; 0.5% (v/v) Tween-20; and 1% (w/v) bovine serum albumin).
Primary antibody, rabbit α-6X His Ab (Rockland) or rabbit α-AlgB Ab, was diluted
1:2000 or 1:1000, respectively, in TBST (1X Tris-buffered saline, pH 7.5; and 0.5%
(v/v) Tween-20), and added to the membranes for 1 hour rocking at room temperature.
The membranes were washed 3 times for 10 min with TBST. The secondary antibody,
goat α-rabbit IgG, was diluted 1:40,000 in TBST and added to the membranes for 1
hour at room temperature. These were washed again 3 times with TBST and
developed using the SuperSignal West Pico Chemiluminescent kit (Pierce). The protein
bands were detected by exposure to X-ray film.
Native PAGE. Purified His-AlgB proteins were combined 1:1 with nondenaturing and non-reducing 2X sample buffer (125 mM Tris-HCl, pH 6.8; 20% (v/v)
glycerol; and bromophenol blue). For each sample, equal amounts of total protein (15
µg) were loaded onto a precast native 10% polyacrylamide gel (BioRad). The gel was
electrophoresed at 100 V in a non-reducing and non-denaturing 1X Tris-glycine buffer
(5X stock; 15.1 g Tris-base, and 94 g glycine per liter). The gel was coomassie stained
as described above.
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Induction and purification of His-tagged AlgB proteins
Induction optimization. Two sets of experiments were performed to
determine optimal conditions for inducing His-tagged AlgB proteins; the first established
a final isopropyl β-D-1-thiogalactopyranoside (IPTG) concentration and the second
ascertained the growth phase for induction. In the first experiment, overnight cultures
of E. coli strain DH5α carrying pJHK12 (His-AlgBwt), 17 (His-AlgBD105K), and 18 (HisAlgBE125K) were diluted 1:100 in 20 mL of LB with ampicillin (100 µg/mL) and grown to
mid log phase (OD600 of 0.5). Four different final concentrations of IPTG were used to
induce each culture (0.5, 1, 3, and 5 mM) and samples were collected 5 and 24 hours
post induction. The cells were pelleted, resuspended in 2X sample buffer and analyzed
by Western blot screening with α-6X His antibody (Rockland). In the second
experiment, subcultures of the same strains were grown to early (OD600 of 0.2), mid
(OD600 of 0.5), and late (OD600 of 0.8) log phase, and induced with 1 mM IPTG final.
Samples were again collected 5 and 24 hours post induction, pelleted, and resuspended
with 2X sample buffer. Lysates were analyzed by Western blot and screened with α-6X
His antibody.
Prevention of protein aggregation. Three modifications were made to either
resolubilize or prevent flocculation of eluted His-tagged AlgB proteins. The first change,
based on a published protocol, supplemented the dialysis buffer (1X TBS) with 50 mM
L-glutamic acid and 50 mM L-arginine (30). The eluted proteins were transferred to a
Slide-A-Lyzer dialysis cassette, 10k MWCO (Pierce) and put into the supplemented
buffer 400 times the total sample volumes. Dialysis occurred for 2 hours at 4°C stirring
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and the buffer was exchanged with fresh 1X TBS (50 mM L-glu and L-arg). The
samples were dialyzed overnight at 4°C stirring. This process was also repeated at
room temperature. However, before the proteins were transferred to the dialysis
cassettes, they were diluted 2, 4, and 8 fold.
The second change altered induction conditions to reduce the amount of total
protein produced by each strain. Overnight cultures of E. coli strain DH5α carrying
pJHK12 and 18 were diluted 1:100 in LB broth and grown to OD600 of 0.2. Each culture
was induced with 100 mM IPTG stock for a final concentration of 5 mM for pJHK18 and
3 mM for pJHK12. These were induced at 37°C for 3 hours and cells were collected.
Proteins were isolated using the His•Bind resin (Novagen) protocol as outlined by the
manufacturer.
The final change made was to the elution buffer, which was used to remove the
His-AlgB proteins bound to the columns. The original buffer contained 20 mM Tris-HCl,
pH 7.9; 1 M imidazole; and 0.5 M NaCl. Two new elution buffers were prepared one
reducing the imidazole concentration to 0.5 M and the second increasing the salt
concentration to 1 M. Strains with pJHK12 and 18 were induced with the modifications
described above and harvested. The cell pellets were lysed with 3 mL of prewarmed
(room temperature) BugBuster HT extraction reagent (Novagen) at room temperature
rocking for 20 min. The lysates were centrifuged for 20 min. at 16,000 xg (4°C) and
the supernatants were collected. The final volumes of each sample were adjusted to 10
mL with 1X binding buffer (20 mM Tris-HCl, 500 mM NaCl, and 5 mM imidazole, pH
7.9). Five milliliters of each lysate were added to 1 mL bed volume of His•Bind resin
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used to purify the proteins. The His-tagged proteins were eluted with 1.5 mL of each
new elution buffer and collected. These were left on the bench top overnight to
observe any protein aggregation.
Ultimate induction and isolation method. Overnight cultures of E. coli
strain DH5α carrying pJHK12 (His-AlgBwt), 18 (His-AlgBE125K), and 23 (His-AlgBR442E)
were diluted 1:100 in 100 mL of LB with ampicillin (100 µg/mL). These subcultures
were grown to early log phase (OD600 of 0.2) and induced with 100 mM IPTG. The final
concentration of inducer for each strain was 3 mM for those carrying pJHK12 and 23,
and 5 mM for the strain with pJHK18. The cultures were further incubated for 3 hours
at 37°C shaking. The cells were harvested by centrifugation, 10,000 xg for 10 min, and
the pellets were stored at -20°C.
For isolating His-AlgB proteins, cell pellets were thawed to room temperature and
resuspended with 3 mL of prewarmed (room temperature) BugBuster HT extraction
reagent (Novagen). These were incubated with a platform rocker for 20 min at 25°C to
allow for lysis and centrifuged at 16,000 xg for 20 min. The supernatants were
collected and 1X binding buffer (20 mM Tris-HCl, 500 mM NaCl, and 5 mM imidazole,
pH 7.9) was added bringing the total volume up to 10 mL. Two milliliters of suspended
His•Bind resin (Novagen) were added to 5 mL centrifuge columns (Pierce) resulting in a
1 mL resin bed volume for protein isolation. The His•Bind protocol was followed as
recommended by manufacturer with the following modification. The 1X elute buffer
used to compete off the His-tagged proteins contained 0.5 M imidazole, which was
determined to allow for continued solubility of the isolated proteins as described above.
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The entire 3 mL elution of each protein was transferred to an Amicon Ultra-4 filtering
unit (10,000 MWCO; Millipore) and centrifuged at 7,500 xg for 10 min. Each protein
was washed three times with 4 mL 1X TBS and concentrated to a total volume of 300
µL. For the ATPase assay, His-AlgBwt and His-AlgBE125K were washed with Buffer B (10
mM Tris-acetate, pH 8.0; 50 mM KCl; 0.1 mM EDTA; 5% glycerol; and 1 mM DTT) and
concentrated to a total volume of 300 µL. The isolated proteins were quantitated as
outlined by the BCA kit (Pierce) and concentrations were determined using BSA
standards provided by the kit. His-AlgB proteins consistently ranged between 0.9 to 2
mg/mL.

Electrophoretic mobility shift assay (EMSA) with AlgB
Biotin 3’ end labeling. DNA probes were selected based on research done by
Leech et al. (43). The specific DNA probe (PalgD300) encompassing the –324 to –24
region was amplified using primers (EMSA1f and EMSA1r), and the nonspecific DNA
probe (PalgDLeader), the leader strand (+1 to +367), was amplified with primers
(EMSAnegf and EMSAnegr). Another specific DNA probe (PalgD534) was also generated
using primers (EMSA2f and EMSA2r), which included the –534 to –1 region. All primer
sets are listed in Table 1. Labeling was accomplished using the Biotin 3’ end DNA
labeling kit from Pierce. After gel purification of the PCR amplified products, the DNA
probes were quantitated via spectrophotometry (OD260). Manufacturer’s protocol was
followed with the following modifications: 1.8 nM of DNA probe was added and 0.5X
final concentration of reaction buffer was used. This kit incorporates 1-3 biotinylated
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ribonucleotides to the 3’ end of single stranded and double stranded DNA utilizing the
terminal deoxynucleotidyl transferase. Once labeled, the percentage of biotinylation
was determined comparing labeled and unlabeled standards provided by the
manufacturer. Two microliters of each standard (0, 25, 50, and 100%) and biotinylated
samples were hand spotted onto a positive zeta charged nylon membrane (Biodyne B
nylon membrane; Pierce). The DNA was cross-linked to the membrane by exposure to
UV using the auto cross-linking function of the Stragene Stratalinker containing 254 nm
bulbs for 45-60 seconds at 120mJ/cm2. The spots were detected using the LightShift
Chemiluminescent EMSA Kit (Pierce) following the manufacturer’s protocol as written
and the membrane was exposed to x-ray film. The labeling process provided a range of
25-70% labeling of the three different probes.
EMSA. For the binding reactions, various buffer conditions and protein
concentrations were involved. Binding buffers used contained 10 mM Tris, 10 mM or 50
mM KCl, and 1 mM DTT at pH 6.5, 7.5, and 8.5. Added to the reaction mixture were
5% glycerol, 5 mM MgCl2, 1 µg/µL Poly(dI•dC), and 0.018 nM of Biotin labeled DNA
probes. Reactions were also done in the presence or absence of 0.1 µg/µL salmon
sperm DNA. The His-tagged proteins used included His-AlgBwt, the mutant HisAlgBE125K, and the helix-turn-helix (HTH) mutant His-AlgBR442E, and concentrations used
were 50 nM, 100 nM, 1 µM, 5 µM, and 10 µM. The binding reactions were incubated
for 20 minutes at room temperature. Five microliters of 5X loading buffer were added
to each and loaded onto a precast 5% polyacrylamide TBE gel (BioRad), which was preelectrophoresed at 100V in 0.5X TBE buffer for 30-60 minutes. The binding reactions
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were transferred to a Biodyne B nylon membrane that was presoaked in 0.5X TBE for at
least 10 minutes. Since no cooling coil was available, the entire transfer box was
surrounded by ice and the samples were transferred at 80 V for 1.5 hours. The DNA
was cross-linked to the membrane via exposure to UV in the Stratalinker at 120
mJ/cm2, and the blot was developed using the LightShift Chemiluminescent EMSA kit
following manufacturer’s protocol. X-ray film was used to document the results.
Competition EMSA. For the competition assays, multiple PCR amplifications of
unlabeled DNA probes were performed. The products were gel purified with the
Qiaquick gel extraction kit and DNA was concentrated using ethanol precipitation as
follows. In brief, one-tenth the volume of 3 M sodium acetate (pH 5.2) and 2 volumes
of ice cold 95% ethanol were added to each gel purified DNA sample. These were
incubated for 1 hour in the –80°C freezer, centrifuged for 10 minutes at 10,000 rpm,
and the pellets were washed once with ice cold 75% ethanol. The pellets were dried
and dissolved in 30 µL of TE buffer. These were quantitated using the
spectrophotometer and read at OD260. The total amount of unlabeled specific
(PalgD300) and nonspecific (PalgDLeader) probes were 4.33 µM and 3.77 µM, respectively.
Competition assays were accomplished combining the same concentration of BiotinPalgD300 with various concentration of unlabeled specific and nonspecific DNA probes to
provide ratios of total DNA (unlabeled + labeled) to total protein of 1:10, 1:15, 1:20,
1:50, 1:100, 1:500, and 1:1000. Protein amounts added for each reaction were 5 µM
His-AlgBwt or 10 µM His-AlgBE125K. The binding reactions were incubated for 20 minutes
at room temperature, loaded onto a precast 5% polyacrylamide TBE gel,
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electrophoresed, and transferred to a nylon membrane. The DNA was cross-linked via
UV exposure and detected by chemiluminescence.

Assay of AlgB ATPase activity
The ATPase assay measuring the release of inorganic phosphate from [γ-32P]
ATP was based on a previously described protocol (24). [γ-32P] ATP (6000 Ci/mmol
specific activity; Perkin Elmer) was diluted to 3 µCi/µL with dH2O. In a 50 µL reaction
volume, 5 µL of 10X assay buffer (500 mM Tris-acetate, pH 8.0; 150 mM potassium
acetate; 270 mM ammonium acetate; 50 mM magnesium acetate; 10 mM DTT; and
30% glycerol), 5 µM His-AlgBwt or His-AlgBE125K protein stored in Buffer B, and 5 µL of
diluted [γ-32P] ATP were combined in the presence or absence of PalgD300 DNA (4.33
pmoles). All reactions occurred at room temperature. Radiolabeled ATP was the final
component added last to the mixture starting the reaction time. Ten microliters of
sample collected at 30 sec, 1 min, and 5 min post ATP addition for each protein were
added to 490 µL of 2 M formic acid to stop ATP hydrolysis. These samples were kept
on ice until the last reaction time point was collected. Two controls were also prepared
both with assay buffer and in the presence or absence of PalgD300 DNA. However, one
contained 15 µCi of [γ-32P] ATP alone and the other contained 15 µCi of

32

P-

orthophosphoric acid (9100 Ci/mmol specific activity; Perkin Elmer) alone. The controls
were allowed to incubate at room temperature for 5 min, and 10 µL of each were
collected and added to 490 µL of 2 M formic acid. Three microliters of each formic acid
mixture were spotted onto two polyethyleneimine (PEI)-cellulose plates (Selecto
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Scientific), one in the absence of DNA and the other in the presence of DNA, for thinlayer chromatography. The spots were air-dried and the plates were soaked in
methanol for 5 min. These were air-dried again and put into a chromatography
chamber containing 0.4 M K2HPO4 and 0.7 M boric acid to allow for ascending
chromatography. Once the buffer reached half an inch from the top, the plates were
removed from the chambers and allowed to air-dry once more. Autoradiography was
performed to visualize the radioactive spots and integrated densitometry values of the
hydrolyzed radiolabeled phosphates were graphed for each protein at each time point.

β-galactosidase assay
Promoter regions of PA1183 (dctA), and PA0603 operon (ABC transporter
operon) including 101 bp upstream and downstream of the promoters were PCR
amplified using primers PPA1183f and PPA1183r; and PPA0603f and PPA0603r, respectively
(Table 1). Restriction sites were incorporated in each set of primers with EcoRI in the
forward and BamHI in the reverse. The PCR products were gel purified using the
QIAEXII kit and cloned into the same sites of vector pSS269, which contains a
promoterless lacZ. The plasmids constructed were pJHK7 (PA1183 promoter), and
pJHK8 (PA0603 operon promoter). These constructs were used to transform chemically
competent DH5α cells and selected on LB agar plates with ampicillin (100 µg/mL). The
insertions were verified by PCR and the plasmids were moved via triparental
conjugation into P. aeruginosa strains PAO1, PDO401, and PDO406. Candidates were
selected on 1/2 PIA with carbenicillin (100 µg/mL).

65
For measuring the promoter activity of the genes listed above, overnight cultures
of each were diluted in LB broth (1:100) and grown to an OD600 of 0.8. On the day of
the assay, 50 mM β-mercaptoethanol (β-ME) was added to 1X Z Buffer (60 mM
Na2HPO4, 40 mM NaH2PO4•H2O, 10 mM KCl, and 1 mM MgSO4; autoclaved and stored
at 4˚C), and 4 mg/mL of ONPG (ortho-nitrophenyl-β-D-galactopyranoside) stock was
prepared using the supplemented 1X Z Buffer. Both were kept on ice. Test tubes
placed in a 28˚C water bath contained 900 µL of 1X Z Buffer + β-ME, and 100 µL of
subculture. For cell permeabilization, 20 µL of 0.1% SDS and 40 µL of chloroform were
added to each tube and vortexed. Incubation of the permeabilized cells continued in
the water bath for 5 min vortexing periodically. After the incubation period, 200 µL of 4
mg/mL ONPG stock was added and vortexed. The timer was immediately started while
the tubes remained in the water bath. Once the solution turned a light yellow, 500 µL
of 1M Na2CO3 was added to stop the β-galactosidase activity and the times were
recorded. The samples were read at an OD420 and OD550. Miller units of βgalactosidase activity was determined using the following equation:
Miller Units = 1000 x

OD420 – (1.75 x OD550)
Time (min) x culture volume (mL) x OD600

The assay was performed in triplicate per strain and average Miller Units were
calculated.

Chromatin immunoprecipitation (ChIP) assay with AlgB
This three-day assay was based on a protocol designed by Leech et al. (43).
Overnight cultures of P. aeruginosa strains were diluted 1:100 in a 100 mL LB broth and
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grown to an OD600 of 0.5. Formaldehyde (1.2% (v/v) final) was added to the cultures
and incubated for 10 min at 37˚C to allow for cross-linking of proteins to DNA. This
reaction was stopped with the addition of glycine (330 mM final) and the cells were
harvested by centrifugation at 5000 rpm (4˚C) for 10 min. The pellets were washed
twice with ice cold TBS and eventually resuspended in 1 mL of FA-lysis buffer (50 mM
HEPES-KOH, pH 7.5; 140 mM NaCl; 1 mM EDTA, pH 8.0; 1% Triton X-100; and 0.1%
sodium deoxycholate) supplemented with 1X EDTA-free protease inhibitor cocktail
(Pierce), lysozyme (5 mg/mL final), and SDS (0.25% final). The latter three were
added fresh on the day of the assay. The suspensions were sonicated using the
Misonix Sonicator S-4000 with the following parameters: 50% output (amplitude) with
ten 2 sec pulses repeated 6 times for each lysate. The sonications were all done on ice
to keep the samples cool. These were centrifuged at 14,000 rpm (4˚C) for 15 min.
The supernatants were divided in half and transferred to fresh microfuge tubes
resulting in two sets of lysates for each sample. Either 500 µL of FA lysis buffer with 5
µL of α-6X His primary antibody or 500 µL of FA lysis buffer containing preabsorbed αAlgB primary antibody were added to the supernatants along with 10 µL of goat αrabbit IgG magnetic beads secondary antibody (3.65 x 1010 particles/mL; NEB). The
eppendorf tubes were put on a rotator and incubated overnight rotating at 4˚C. The
next day, the magnetic beads containing targeted antibody complexes (2˚ α-rabbit IgG
Ab, 1˚ α-6X His or α-AlgB Ab, and His-AlgB proteins cross-linked to promoter DNA)
were isolated using a magnetic separation rack (NEB). These were washed once with
500 µL FA lysis buffer and once with 500 µL of FA lysis buffer containing 500 mM NaCl
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(final). They were also washed multiple times with Buffer III (10 mM Tris-HCl, pH 8.0;
1 mM EDTA, pH 8.0; 250 mM LiCl; 1% IGEPAL; and 1% sodium deoxycholate), and
finally three times with 10 mM Tris-HCl (pH 8.0). The His-AlgB proteins cross-linked to
promoter DNA were eluted from the magnetic complexes twice with 100 µL of elution
buffer (50 mM Tris-HCl, pH 7.5 and 1% SDS; stored at 25˚C) incubated for 10 min at
60˚C. Two hundred microliters of Tris-HCl (pH 8.0) and 6 µL of proteinase K (10
mg/mL) were added to the 200 µL elution and incubated overnight at 65˚C. The DNA
fragments were extracted from the mixture via the phenol/chloroform method. One
volume of phenol/chloroform (1:1) was added to the sample and vortexed. This was
centrifuged for 15 min at 14,000 rpm (4˚C) and the top aqueous layer was retained.
One-tenth volume of 3 M sodium acetate (pH 5.2), 3 volumes of 95% ethanol (ice
cold), and 10 µL of yeast tRNA carrier (15 µg/µL; Invitrogen) was added to the aqueous
layer. The mixture was incubated at –70˚C for one hour and then centrifuged for 15
min at 14,000 rpm (4˚C). The DNA pellets were washed once with ice cold 75%
ethanol, dried briefly, and eluted with 100 µL of MQ. PCR reactions were performed
using the eluted DNA fragments as template and primers, algBIPf and algBIPr, to
amplify within the leader strand of PalgD and primers, ChIPnegf and ChIPnegr, to
amplify a promoter that is not AlgB regulated (Table 1).
Preabsorbed α-AlgB antibody. Polyclonal α-AlgB antibodies were
preabsorbed using lysates of JK159, PAO ΔalgB-kinB. The parameters of this assay
were first developed for screening P. aeruginosa lysates via Western blot analysis to
determine the stringency of preabsorption for the ChIP assay. Overnight cultures were
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diluted 1:100 in LB broth and grown to an OD600 of 1. Twenty-three milliliters of the
subculture were transferred to a 15 mL conical tube, incubated in boiling water for 15
min, and cooled completely. AlgB antibody was diluted in TBST and the amount of
JK159 lysate added contributed to the total volume of the dilution, which was 40 mL.
Two different volumes of lysate were used for the preabsorption, 2 mL and 20 mL
(final). Forty microliters of α-AlgB stock was diluted in 38 mL of TBST for the first
lysate volume and 20 mL of TBST for the second lysate volume. There were two
preabsorption steps, the first added half the lysate volume (1 mL and 10 mL) to the
diluted antibody, rocked at room temperature for 2 hours, and centrifuged at 5000 rpm
for 10 min (4˚C). The second step added the remaining lysate volume to the
appropriate supernatants resulting in final volumes of 40 mL of diluted antibodies.
These were incubated rocking overnight at 4˚C and centrifuged at 5000 rpm for 10 min
(4˚C). The supernatants were used as the primary antibody for screening PVDF
membranes containing lysates of PAO1, JK159, and JK159 (pJHK13). These were
compared to Western blot analyses of lysates screened with nonpreabsorbed α-AlgB Ab
in TBST (1:1000).
For the ChIP assay, α-AlgB antibody was preabsorbed with two different
concentrations of JK159 lysates. The overnight culture of JK159 was diluted in LB broth
(1:100) and grown to an OD600 of 1. For the first concentration of lysate, 3 mL of
subculture were incubated in boiling water for 15 min and cooled completely. For the
second concentration, which was more stringent, 10 mL of subculture were harvested
by centrifugation at 10,000 rpm (4˚C) for 10 min. The cell pellet was resuspended in 3
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mL of TBS, incubated for 15 min in boiling water, and cooled completely. Forty
microliters of α-AlgB antibody were diluted in 2 mL of FA-lysis buffer. One milliliter of
lysate at either concentration was added to the dilution and incubated for 2 hours on a
platform rocker at 25˚C. These were centrifuged at 5000 rpm (4˚C) for 10 min and the
supernatants were retained. Another 1 mL of lysate was added and the mixture was
incubated on the platform rocker overnight at 4˚C. These suspensions were
centrifuged at 5000 rpm (4˚C) for 10 min and the supernatants were retained resulting
in total volume of 4 mL. Five hundred microliters of the preabsorbed α-AlgB antibody
were used for each sample in the ChIP assay as described previously.
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Table 1. Bacterial strains, plasmids, and oligonucleotides
Strain, plasmid,
or oligonucleotide

Characteristic(s) or sequence

Source or
reference

Strains
Escherichia coli
DH5α

–

F φ80Δ(lacZ)M15 Δ(lacZYA-argF)U169 deoR phoA
–

Lab collection

supE44 gyrA96 recA1 endA1 λ thi-1 hsdR17
MC1061

araD139 Δ(ara-leu)7696 galE15 galK16 Δ(lac)X74 rpsL
hsdR2 mcrA mcrB1

Pseudomonas aeruginosa
–
PAO1
Wildtype; Alg

Lab collection
+

PDO300

PAO mucA22; Alg

PDO401

PAO algB::Gm; Alg

PDO402

PDO300 algB::Gm; Alg

PDO406

PAO kinB::Gm; Alg–

JK159

PAO ΔalgB-kinB; Alg

JK215

PAO ΔalgB-kinB algT::Gm; Alg

JK229

PAO rpoN::Gm; Alg

JK231

PAO ΔalgB-kinB rpoN::Gm; Alg

JK260

PDO300 rpoN::Gm; Alg

Plasmids

Christie Lab

Lab collection

–

Lab collection
–

Leech, 2008
Leech, 2008

–

This study
–

–

This study
–

+

r

pEX100T

ColE1 Amp oriT sacB

pTrcHisA

ColE1 Amp lacI Ptrc 6x His tag vector

pUC19

ColE1 Amp

pUCGM1

ColE1 Amp Gm

pRK2013

ColE1-Tra(RK2) Km

r

This study

This study
This study

Schweizer, 1995

q

Invitrogen

r

Schweizer, 1993

r
r

+

r

Figurski, 1979
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pSS124

pUC1918 + 1.2 kb mSF

Suh, 2004

pSS269

pSS223 lacZ mSF oriT Amp

pJHK5

pSS269 + 709 bp EcoRI-BamHI PCR fragment;
PA4446 (algW) promoter

This study

pJHK7

pSS269 + 537 bp EcoRI-BamHI PCR fragment;
PA1183 (dctA) promoter

This study

pJHK8

pSS269 + 435 bp EcoRI-BamHI PCR fragment;
PA0603-PA0606 operon promoter

This study

pJHK11

pEX100T + 2kb (upstream and downstream
fragments around algB-kinB operon)

This study

pJHK12

pTrcHisA + 1.35 kb BamHI-HindIII PCR fragment;
wild type AlgB

This study

pJHK13

pJHK12 + 1.2 kb SphI fragment of pSS124; mSF

This study

pJHK14

pUC19 + 1.35 kb BamHI-HindIII fragment of
pJHK12; wild type AlgB

This study

pJHK15

pUC19 + 1.35 kb BamHI-HindIII PCR fragment;
AlgBD105K

This study

pJHK16

pUC19 + 1.35 kb BamHI-HindIII PCR fragment;
AlgBE125K

This study

pJHK17

pTrcHisA + 1.35 kb BamHI-HindIII fragment from
pJHK15; AlgBD105K

This study

pJHK18

pTrcHisA + 1.35 kb BamHI-HindIII fragment from
pJHK16; AlgBE125K

This study

pJHK19

pJHK17 + 1.2 kb SphI fragment of pSS124; mSF

This study

pJHK20

pJHK18 + 1.2 kb SphI fragment of pSS124; mSF

This study

pJHK21

pTrcHisA + 1.2 kb SphI fragment of pSS124; mSF

This study

pJHK22

pUC19 + 1.35 kb BamHI-HindIII PCR fragment;
AlgBR442E

This study

pJHK23

pTrcHisA + 1.35 kb BamHI-HindIII fragment from
pJHK22; AlgBR442E

This study

pJHK28

pJHK23 + 1.2 kb SphI fragment of pSS124; mSF

This study

r

Suh, 2004
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pJHK24

pEX100T + 1.5 kb PCR fragment; rpoN

This study

pJHK25

pJHK24 + 900 bp PstI fragment from pUCGM1

This study

pJHK26

Inverse PCR removing first 438 bp of algB from
pJHK13; AlgBΔ1-145

This study

pJHK30

pJHK21 + 1.5 kb EcoRI-HindIII PCR fragment;
rpoN

This study

upalgBf

GCACCTGCACGTAGAGCCCG

This study

upalgBr

atcgtggatccCGTTGCTTTTTATCCTCTAGGGAA

This study

downkinBf

atcgtggatccCCGGGCCCGCTCCCGGCA

This study

downkinBr

TACTGCGCTGATCCTGCTGCA

This study

algBf

ATGGAAACCACTTCCGAAAAACAG

This study

algBr

ATAGGCCGTACTGCTTGCGC

This study

HisAlgB1f

gatggggatccgagATGGAAACCACTTCCGAAAAACAG

This study

HisAlgB1r

gatggaagcttTCATAGGCCGTACTGCTTGCGC

This study

HisAlgB2f

GGCGCGGTGAAGTACCTGGTC

This study

HisAlgB2r

GACCAGGTACTTCACCGCGCC

This study

HisAlgB3f

CAAGCAACTGAAGGTGCGCCA

This study

HisAlgB3r

TGGCGCACCTTCAGTTGCTTG

This study

HisAlgB4f

ACCCTGTACGAGAAGCGCAAG

This study

HisAlgB4r

CTTGCGCTTCTCGTACAGGGT

This study

pTrcHisAr

CTGCGTTCTGATTTAATCTGTATC

This study

HisAlgB5f

CTGGAATCGCACAGCCCGGC

This study

HisAlgB5r

CTCGGATCCCCATCGATCCTTA

This study

algTf

TGTTGGCTCATGCCCGCATTTC

This study

algTr

TCACGACTCATAGCGATACCTC

This study

rpoNf

ATGAAACCATCGCTAGTCCTCA

This study

Oligonucleotides
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rpoNr

TCACACCAGTCGCTTGCGCT

This study

HisRpoN2f

gatgggaattcATGAAACCATCGCTAGTCCTCA

This study

HisRpoN1r

gatggaagcttTCACACCAGTCGCTTGCGCT

This study

omlARTf

CGGCGTCAGCCGCGACGAA

This study

omlARTr

CGGTTTCGGCGGCTCTTCTTTCT

This study

algDRT3f

ACGCGGTCATGAAGTCATTGGT

This study

algDRT3r

ACGATACGTCGGAGTCCAGCAC

This study

EMSA1f

AAGGCGGAAATGCCATCTCC

Leech, 2008

EMSA1r

AGGGAAGTTCCGGCCGTTTG

Leech, 2008

EMSA2f

TCTCCCCGGCCCGCCGTC

This study

EMSA2r

GGTGATAGGATGTTTTCTCTGCG

This study

EMSAnegf

GCGATGCCTATCGATAGTTATG

This study

EMSAnegr

CGCATTCACCTCGATTGTTTGT

This study

PPA1183f

atcgtgaattcATGCCGGCGCGACGCAGCAG

This study

PPA1183r

atcgtggatccGCCACCGCCGTTTCCGGGTAC

This study

PPA0603f

atcgtgaattcCGCCGCAGAACATGCAGAA

This study

PPA0603r

atcgtggatccATGTCCAGGTTGAGATCCTTC

This study

algBIPf

GCAGAGCAACTTGAAACCGTCTC

Leech, 2008

algBIPr

GCCGTTACTACGAGCCCCG

Leech, 2008

ChIPnegf

CATGCACTGGCTGGACTACC

Leech, 2008

ChIPnegr

AGCGAGCGCCCGCCGTCATG

Leech, 2008

Lowercase nucleotides were added to the gene specific sequence and bold nucleotides represent restriction sites.
Underlined nucleotides were changed from the original sequence.

Chapter 3: Identification of an AlgB variant that induces alginate
biosynthesis in nonmucoid P. aeruginosa PAO1

Rationale for mutagenesis to obtain an overactive AlgB
One of the most important and useful tools for studying the NtrC family of
response regulators was the discovery of overactive mutants. Not only are these
mutants independent of their cognate sensor kinases, they also afford a homogenous
population of activated regulators. Advancements made to further understand the role
and regulation of these proteins after activation have been achieved because of these
mutants.
In order to study AlgB as a two-component regulator, my first goal was to obtain
an overactive form. Research randomly mutating an AlgB homologue, DctD, results in
proteins with continuous activity for ATP hydrolysis and transcription (55). An amino
acid sequence alignment was done to compare the two regulators showing an overall
homology of 55% and a sequence identity of 36% (Figure 7). Two of the amino acid
modifications in DctD resulting in two overactive mutants were D101K and E121K (55).
These same two residues corresponding to D105 and E125 were conserved in AlgB. I
hypothesized that by substituting these two amino acids with lysine, two overactive
forms of AlgB would also be produced.

74

75

Figure 7. Sequence alignment between Rhizobium meliloti DctD and
Pseudomonas aeruginosa AlgB. The two amino acid sequences, DctD (36) and
AlgB (76) were aligned using the BLASTp program offered by NCBI. Numbers on the
right and left represent the positions of the residues within their respective
polypeptide. Letters between the sequences are identical matches and plus signs
indicate similar properties based on the side chains. The two conserved amino acids,
D101 and E121, of DctD corresponding to D105 and E125 of AlgB are boxed in red.
The lysine, K, above the red boxes indicates the substitution. Rm – Rhizobium meliloti
and Pa – Pseudomonas aeruginosa
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Construction of His-AlgBD105K and His-AlgBE125K. The two separate
mutations made in AlgB were accomplished using site-directed mutagenesis.
Manipulations were performed utilizing AlgB from PAO1, a nonmucoid strain of

Pseudomonas. Figure 8A depicts the process leading to the construction of the DNA
cloning fragments. A single and a double nucleotide substitution were generated to
convert D105 and E125 to lysines (K), respectively. These mutated algB genes and wild
type algB were cloned into pUC19 and outsourced to Eurofins MWG Operon for DNA
sequencing. The wild type sequence was an exact match to the published sequence of
PAO1 (76). The mutated sequences compared to wild type contained only the intended
mutations and no other spontaneous changes. All of the algB genes were subsequently
cloned into the pTrcHisA vector adding six histidine residues to the N-terminal portion of
the proteins for subsequent biochemical assays and allowing for IPTG induction (Figure
9A). A stabilizing fragment, mSF, was also added to each vector to allow for their
maintenance within P. aeruginosa. The constructs produced were pJHK13 (His-AlgBwt),
pJHK19 (His-AlgBD105K), and pJHK20 (His-AlgBE125K) as shown in Figures 8B and 9B.
His-AlgB constructs complemented PDO402. Complementation assays
were performed to verify the proper folding and functionality of the His-tagged AlgB
proteins. Each plasmid above was electroporated into PDO402 (PDO300 algB::Gm).
The background strain, PDO300 (PAO1 mucA22), has a deregulated sigma 22 allowing
for the production of alginate. Introduction of a gentamicin cassette into the algB gene
of PDO300 prevents alginate expression resulting in a nonmucoid phenotype for
PDO402. It was hypothesized that each His-AlgB construct added in trans would
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Figure 8. Mutagenesis of AlgB at the conserved amino acid residues, D105
and E125. A. Diagram illustrating the construction of two AlgB mutants via sitedirected mutagenesis. Single and double nucleotide substitution were generated to
replace D105 and E125 with lysine (K), respectively. For each mutation, two PCR
amplifications were performed to achieve full-length algB with the intended codon
change. Details of their construction are found in Materials and Methods. B.
Completed His-tagged constructs of pJHK19 and pJHK20 containing AlgBD105K and
AlgBE125K, respectively.
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Figure 9. His-tagged AlgBwt construct. A. Illustration of the strategy to create
the His-AlgBwt construct. The PCR amplified algB gene was cloned into the pTrcHisA
vector. Stabilizing fragment (mSF) was also cloned into the vector following digestion
from pSS124, a genetic tool developed by Suh et al. (79). Details of this process are
found in Materials and Methods. B. Completed His-tagged construct of pJHK13 with
wild type AlgB.
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compensate for the chromosomal algB::Gm mutation resulting in alginate production
and mucoid colonies. Even the mutant AlgB proteins (D105K and E125K) were
predicted to activate the alginate operon, since previous research showed that alginate
expression by the FRD1 (mucA22) strain was unaffected in the presence of an Nterminally deleted (Δ1-145) AlgB (45), and both of the single amino acid substitutions
were within the deleted region. All three His-AlgB variants complemented the algB
mutation in PDO402 resulting in alginate production. Figure 10 shows the mucoid
colonies of this strain carrying pJHK13 (His-AlgBwt) as well as the mucoid background
strain, PDO300, and the nonmucoid recipient strain, PDO402. Complementation was
also observed for the mutant AlgB proteins (data not shown). These results confirmed
that the regulators are properly folded and functional.
Construction of PAO ΔalgB-kinB strain. Before these His-tagged vectors
were introduced to P. aeruginosa PAO1, I constructed a deletion strain removing the
entire algB operon, which included not only algB but also its cognate sensor kinase,

kinB. The rationale for this deletion was to ensure that any observed effects were due
to the AlgB proteins expressed from the His-tagged constructs and not from the
genome. KinB effects would also be eliminated guaranteeing a overactive AlgB mutant,
defined as independent of KinB, if transcriptional activation were to occur. Removal of
the algB operon was accomplished via a double recombination method using a suicide
vector, pEX100T, lacking the stabilizing fragment needed for replication. This process is
illustrated in Figures 11A and B. Upstream and downstream regions
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Figure 10. Plate phenotypes of complementation assay. PDO402, PDO300,
and PDO402 (pJHK13) were streaked onto a 1/2 PIA plate. The double mutant strain,
PDO402, derived from PDO300 with an algB insertion mutation appeared nonmucoid
since AlgB is important for the generation of alginate. The background strain,
PDO300, showed colonies with mucoid phenotype due to copious amount of alginate
production. The addition of pJHK13 (His-AlgBwt) to PDO402, complemented the algB
insertional mutation returning the alginate-producing phenotype.
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Figure 11. Diagram of the process used to delete the algB operon from
PAO1. A. Preparation of the suicide construct. Upstream and downstream regions
surrounding the algB operon were PCR amplified and ligated together via a BamHI
restriction site (left gel image with the ligated fragments at 2 kb). The insertion
segment was PCR amplified (right gel image) and cloned into a suicide vector,
pEX100T. B. Construction of JK159, PAO ΔalgB-kinB, strain. The prepared suicide
plasmid was conjugated into PDO401 and a double crossover event was encouraged
to remove the algB operon from the genome. Double recombinants were selected on
1/2 PIA with 6% sucrose and were verified to be carbenicillin and gentamicin
sensitive. C. Confirmation of the removal of the algB operon. PCR was performed
amplifying the algB gene. PAO1 and PDO401, control strains, exhibited amplification
bands at 1.35 and 2.2 kb, respectively. The two candidates that grew in the presence
of sucrose and were sensitive to both carbenicillin and gentamicin did not produce any
amplification products. Therefore, the algB operon was deleted.
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surrounding the operon were cloned into pEX100T and transferred to strain PDO401
(PAO algB::Gm) by triparental conjugation. Merodiploids were initially selected for
resistance to carbenicillin. Subsequently, double recombinants (Figure 11B) were
chosen that were able to grow in the presence of 6% sucrose with the loss of the sacB
gene located on the vector. These candidates were also verified for sensitivity to
carbenicillin and gentamicin indicating the loss of these antibiotic resistant cassettes
located on the plasmid and in the chromosomal algB gene, respectively. Deletion of the

algB operon was confirmed via PCR amplification of the algB gene (Figure 11C). Both
PAO1 and PDO401 showed amplification products at 1.35 and 2.2 kb, respectively.
PDO401 had a larger amplicon because of the gentamicin insertion in the algB gene.
Both JK159 candidates (1 and 2) showed no product bands indicating the loss of the
gene and therefore the loss of the operon. Subsequent PCR using primers surrounding
the algB operon also confirmed its deletion (data not shown).

His-AlgBE125K promoted alginate production
Once the JK159, PAO ΔalgB-kinB, strain was made, the three His-AlgB plasmids,
pJHK13, 19, and 20, were mobilized into this strain via electroporation. Carbenicillin
was used to select for candidates carrying the desired constructs. Unexpectedly, the

algB-kinB deletion strain, which is nonmucoid, began expressing alginate when pJHK20
was introduced (Figure 12C). The other two constructs did not result in colonies of
mucoid phenotype (Figures 12A and B). The His-tagged AlgB carried by pJHK20 was
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Figure 12. Plate phenotypes of JK159 strain carrying each of the three HisAlgB variants. A. The strain with pJHK13 (His-AlgBwt) displayed nonmucoid colonies
with similar morphology to wild type PAO1 and to JK159 alone. B. The strain with
pJHK19 (His-AlgBD105K) showed the same phenotype as in A. C. The strain with
pJHK20 (His-AlgBE125K) induced alginate production and generated mucoid colony
morphology.
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the mutant variant with a substitution of E125 to K. In order to determine the amount
of alginate produced in the presence of each His-AlgB construct compared to wild type
PAO1, the borate-carbazole assay was used. This assay measures levels of uronic acid,
monomer units of alginate, since currently there is no assay to measure full-length
alginate polymer. Briefly, uronic acids secreted by each strain grown overnight in LB
broth with or without carbenicillin were precipitated using 95% ethanol. The
precipitated uronic acids were dissolved in MQ water and subjected to the boratecarbazole assay converting the uronic acids to furan compounds that react with
carbazole forming a red chromophore. The chromophore was measured
spectrophotometrically at OD530, and a standard curve generated from commercially
available Na-alginate was used to calculate the amount of uronic acids measured (µg).
These values were normalized against total cell pellet weight (g) harvested from each
overnight culture and graphed as shown in Figure 13. Wild type PAO1 produced very
low levels of uronic acid per cell pellet weight (508.89 ± 144.52 µg/g). Similar levels
were seen by the algB-kinB deletion strain carrying either pJHK13 (473.59 ± 190.24
µg/g) or pJHK19 (478.28 ± 114.03 µg/g). The strain with pJHK20 measured at
2,667.96 ± 609.55 µg of uronic acid/g of cell pellet, which was 5-fold greater than and
significantly different from PAO1. This corresponded to the mucoid phenotype
observed from the plate morphology. However, the amount of full-length polymer
produced by JK159 (pJHK20) was not as abundant as PDO300, which was visually
obvious based on colony morphology and was measured at 23,248.89 ± 6545.15 µg/g.
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Figure 13. Graph of average uronic acid levels produced by each
Pseudomonas strain. Strains of JK159 carrying each of the plasmids (pJHK13, 19,
and 20) were compared to wild type PAO1. The amount of uronic acids was
determined using the borate-carbazole method. A standard curve of commercially
available Na-alginate was used to determine the levels of uronic acid. These values
were normalized to total cell pellet weight and the average normalized values were
graphed. Uronic acids were precipitated from three separate overnight cultures for
each strain and the borate-carbazole assay was done in duplicate for each culture.
NM and M represent nonmucoid and mucoid phenotypes, respectively.
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His-AlgBE125K promoted transcriptional activation of the algD operon
Since a significant amount of alginate was produced by the JK159 (pJHK20)
strain, I wanted to determine whether this was due to an increase in the amount of
alginate transcripts, which would signify that regulation occurred at the transcriptional
level. Transcript amounts were analyzed via RT PCR and real time RT PCR (qRT PCR).
For both assays, total RNA was harvested from the following Pseudomonas strains:
PAO1, PDO300, JK159, JK159 (pJHK13), and JK159 (pJHK20) grown to late log phase.
The RNA was treated with DNAse I to remove any contaminating genomic DNA and ran
on a formaldehyde 1.2% agarose gel to assess the integrity of the 16S and 23S rRNA.
A 260/280 ratio was also calculated to determine the quality of the total RNA. Intact
rRNA bands and a ratio between 1.8 and 2.0 indicated clean, good quality total RNA.
Reverse transcription using two gene specific reverse primers converted 1 µg of total
RNA to single stranded cDNA. A negative (No RT) control was simultaneously prepared
containing all of the components of the assay minus the reverse transcriptase enzyme.
The two genes chosen were omlA (internal control gene) coding for the outer
membrane protein A, which had been previously used as an internal constitutive control
(81), and algD (target gene) found as the first gene in the alginate operon. For the RT
PCR method, 2 µL of gene specific cDNA and No RT control were PCR amplified using
the appropriate forward and reverse primers. The PCR products were equally loaded
onto a 1% agarose gel and visualized by UV. Figure 14 displays these results.

95

Figure 14. RT PCR results showing transcript levels of omlA and algD from
the different strains of Pseudomonas. None of the Pseudomonas strains showed
PCR product for the No RT control indicating the absence of genomic DNA in the total
RNA samples. Similar amounts of omlA transcript were seen for each strain.
However, for algD, there were obvious transcript level differences expressed.
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As expected, the No RT control showed no product bands confirming the absence of
any contaminating genomic DNA in the total RNA samples. All of the Pseudomonas
strains contained similar levels of omlA transcript. However, dramatic differences were
seen in the extent of algD expression for each strain. PAO1 and JK159 displayed the
least amount of algD transcript and PDO300 had the most correlating to their
nonmucoid and mucoid phenotypes, respectively. JK159 (pJHK13) expressed a little
more algD than PAO1 or the algB-kinB deletion strain, however, this level of expression
was not enough to result in an alginate producing phenotype. The deletion strain
carrying pJHK20 contained the second highest level of algD transcript after PDO300.
This was not surprising since JK159 (pJHK20) produced alginate at much lower levels
compared to PDO300. Yet, the amount of transcript seen for JK159 (pJHK20) was still
considerably greater than PAO1.
In order to quantitate the amount of algD transcripts expressed by each of the

Pseudomonas strains, real time RT PCR was performed using the SYBR green method.
This method employs the SYBR green fluorophore, which specifically intercalates double
stranded DNA and fluoresces only after binding. Since this fluorophore is not gene
specific, it will bind to any double stranded DNA. Therefore, I had to initially optimize
the real time conditions for each primer set (omlA and algD) so that the primer
efficiencies were between 80-120%. The cDNA samples were two fold serially diluted
and amplified using an annealing temperature gradient. The cycle threshold, Ct,values
were graphed against the log cDNA concentrations. Primer efficiencies were calculated
based on the slope. Annealing temperatures resulting in ~90% primer efficiencies for
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omlA (55°C) and algD (63.3°C) were chosen. The gene-specific cDNA for each strain
was added to the SYBR green master mix and amplified using the optimized annealing
temperature determined for each gene. The Ct value for algD was normalized against
the Ct value for omlA within a single Pseudomonas strain. Fold changes were calculated
comparing normalized values to PAO1 (Figure 15). There was no detectable change in

algD transcript between JK159 and PAO1 as previously seen by RT PCR in Figure 14.
The algB-kinB deletion strain carrying pJHK13 had a 3-fold increase in algD compared
to PAO1, which was significant, but apparently not enough to generate a mucoid
phenotype. JK159 with pJHK20 had an 11-fold increase in algD transcript, which was
also significantly different compared to algD measured for PAO1.

Effect of His-AlgBΔ1-145 on alginate production
Researchers have established that N-terminal deletion has opposite effects on
NtrC and DctD. For NtrC, activation of the regulator never occurs because this process
is dependent upon phosphorylation. However, for DctD, the truncated form is
overactive indicating an inhibitory role accomplished by the N-terminal domain. Since
one of the mutant AlgB constructs, His-AlgBE125K, mimicking the same mutation in DctD,
resulted in alginate production, it is hypothesized that the N-terminal deletion of AlgB
would also generate an overactive mutant activating the alginate operon. Construction
of the truncated mutant was accomplished via inverse PCR using pJHK13 (Figure 16).
Primers were designed excluding 438 bp of the algB

99

Figure 15. Real time RT PCR results showing the average fold changes of
algD transcript compared to PAO1. No fold change in algD was observed with JK
159 compared to PAO1. There was a 3-fold increase and an 11-fold increase in algD
transcript for JK159 (pJHK13) and JK159 (pJHK20), respectively. Both of these
increases were significant over no fold change. The normalized values were of three
separate cultures for each strain. NM and M represent nonmucoid and mucoid
phenotypes, respectively.
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gene representing the first 145 amino acids. The remaining portion of the pJHK13
plasmid (6.5 kb) was PCR amplified and ligated together generating pJHK26. The
deletion was verified via PCR using primers to the entire algB gene and primers to the
shortened algB fragment. Constructs that were chosen only had amplicons to the
truncated region. This plasmid was electroporated into JK159 and selected on 1/2 PIA
with carbenicillin. The candidates based on plate phenotype did not appear mucoid. A
uronic acid assay was also performed on overnight broth cultures. No difference was
seen in the amount of uronic acid produced by JK159 (pJHK26) compared to PAO1
(Figure 17). Therefore, the N-terminal deletion mutant of AlgB was not overactive and
did not activate alginate production.
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Figure 16. Construction of AlgB N-terminal deletion mutant via inverse
PCR. Primers (red) were generated to pJHK13 excluding 438 bp of the algB gene
corresponding the first 145 amino acids. PCR amplification generated a 6.5 kb product
(gel image on right) that was ligated together resulting in pJHK26. The deletion was
verified by amplifying either the entire 1.35 kb algB gene (left half of bottom gel
image) or the truncated 912 bp portion (right half of bottom gel image). Constructs
that showed product bands only for the truncated gene were chosen.
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Figure 17. Graph of average uronic acid levels produced by PAO1 and JK159
(pJHK26). Uronic acids were ethanol precipitated from overnight broth cultures of
each strain. The amount secreted was determined using the borate-carbazole
method, and the values were normalized to total cell pellet weight. No differences
were seen in the uronic acid levels between the strain carrying the N-terminally
deleted AlgB and PAO1. Uronic acids were precipitated from three separate overnight
cultures for each strain and the borate-carbazole assay was done in duplicate for each
culture. NM represents nonmucoid phenotype.
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Discussion
The discovery of overactive response regulators from the NtrC family has
transitioned scientists to another level of understanding for these proteins. Researchers
have been able to obtain knowledge relating structure to function of these activated
regulators as well as conformational changes observed in this state (24, 41, 62, 72).
Not only have these overactive forms contributed significant information but they have
also afforded a more manageable situation for studying the activated state of these
proteins. These mutants are kinase independent and they provide a homogenous
population since their ability to autodephosphorylate does not return them to an
inactive state. In this study, I wanted to generate an overactive AlgB mutant. Previous
research randomly mutagenizing DctD resulted in two overactive mutants with amino
acid substitutions D101K and E121K (55). A sequence alignment between AlgB and
DctD revealed that these same two amino acids were conserved in AlgB (D105 and
E125). I hypothesized that mutating these residues to lysines would also render AlgB
overactive. These mutations were accomplished via site-directed mutagenesis and
verified by sequencing. Eventually, the wild type and the mutant forms of algB were
cloned into pTrcHisA, which was important for future biochemical assays requiring
purified AlgB proteins. Complementation assays demonstrated that each of the HisAlgB proteins, expressed in trans, were folded properly and were functional. They were
all able to complement the algB insertional mutation of PDO402 allowing for the
expression of alginate and the creation of a mucoid colony phenotype. It was not
surprising that the two mutant forms of AlgB were able to show complementation
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because it had been previously demonstrated that the N-terminal domain was not
required for alginate activation (45), and both mutations were within this region. A
PAO ΔalgB-kinB, JK159, strain was also constructed in this study. It was important to
remove the algB operon in order to avoid any effects that might be a consequence of
proteins expressed from the chromosome. Also, since the objective was to identify an
overactive AlgB mutant, any promoter activity displayed by the His-AlgB variant would
be guaranteed to be KinB independent.
Once the His-AlgB constructs were introduced to the JK159 strain, an unexpected
phenotype resulted with the addition of only one of the plasmids, pJHK20 (HisAlgBE125K). The plate phenotype for this strain was mucoid indicating the production of
alginate, which was significant compared to PAO1 based on the uronic acid assay. It
was subsequently determined that this activation occurred at the transcriptional level.
RT PCR and real time RT PCR were performed using omlA as the internal control gene,
and algD, the first gene in the operon, as the target. Both assays revealed a definite
increase the level of algD transcript for the strain with His-AlgBE125K compared to PAO1
and JK159. The real time RT PCR data showed an 11-fold increase in algD transcript
which was significantly different compared to algD levels for PAO1. Alginate induction
by His-AlgBE125K was surprising because previous research by Ma et al. (45) had
concluded that phosphorylation of AlgB is not required for alginate production. This is
determined using a deregulated sigma 22 background strain and assessing the
inhibition of alginate. Since none of the AlgB phosphorylation mutants prevents
alginate production, activation of the algD operon does not require phosphorylated AlgB
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(45). This is true if the algD operon is continually being activated under sigma 22
control. However, with this new discovery, I conclude that an alternative regulation of
the alginate operon might be occurring when sigma 22 is tightly regulated. These data
collectively suggest that an overactive mutant, His-AlgBE125K, is obtained allowing for the
increased transcriptional activation of the alginate operon.
Lastly, I wanted to investigate whether the N-terminal or receiver domain of AlgB
functioned similarly to either NtrC or DctD. Interestingly, research has shown that the
N-terminus functions differently for both NtrC and DctD. For the former, this domain is
necessary for the activation of the protein because phosphorylation is essential in the
oligomerization process of the regulator (15, 55). For the latter, the N-terminus acts as
an inhibitor of the central, ATPase, domain, which is intrinsically active. Removal of the
receiver domain generates an overactive DctD (55). For this study, I constructed an Nterminal deletion mutant of AlgB removing the first 145 amino acids and determined
whether this mutant was overactive by investigating its effects on alginate production.
This construct was introduced to JK159 via electroporation and based on plate
morphology the colonies were nonmucoid. The uronic acid assay confirmed the plate
results and revealed no difference in the levels produced compared to PAO1.
Therefore, the AlgB central domain is not intrinsically competent and that the Nterminal domain does not function similarly to DctD. These data, however, are
insufficient to determine whether the receiver domain functions similarly to NtrC.

Chapter 4: Transcriptional regulation of the algD operon for alginate
biosynthesis by His-AlgBwt and His-AlgBE125K is dependent upon sigma 54

Rationale for investigating sigma 22 and sigma 54
Once I determined that the alginate produced by JK159 (pJHK20) is activated at
the transcriptional level, I investigated two possible sigma factors involved in this
activation process, σ22 and σ 54. Focus was directed towards both of these sigma
factors for the following reasons. Sigma 22 (AlgT) has been well established as the
predominant sigma factor involved in alginate regulation (25, 26). Additionally, when
deregulated, this sigma factor is responsible for the mucoid conversion of P. aeruginosa
isolated from the lungs of chronically infected CF patients (48). Sigma 54 (RpoN) has
also been demonstrated to activate the algD operon in one strain of Pseudomonas
carrying an uncharacterized mutation, muc23 (10). Furthermore, this sigma factor is
generally associated with the NtrC family of response regulators since it requires the
ATPase function of these regulators to provide energy for open complex formation and
promoter clearance (34). Since I believed that His-AlgBE125K is an overactive mutant of
AlgB functioning as a two-component regulator, I hypothesized that activation of the

algD operon with this mutant form is dependent upon sigma 54.
Construction of sigma factor mutants. Investigation of both σ22 (AlgT) and
σ54 (RpoN) began with constructing mutations in strains of P. aeruginosa. The σ22
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(AlgT) mutation was easily accomplished using an already available stock strain of PAO

algT::Gm, which is part of the lab collection. The algT::Gm mutation was mobilized to
JK159 strain using a very efficient and relatively simple process of generalized phage
transduction generating a triple mutant (Figure 18A). Candidates designated as JK215
were selected using gentamicin and verified by PCR amplification to ensure the
presence of the gentamicin cassette in the algT gene (Figure 18B).
The σ54 (RpoN) mutation had to be newly constructed because collection strains
presumably containing an RpoN insertional mutation did not actually have an antibiotic
cassette within the rpoN gene. Figure 19A and B illustrates the development of the
genetic construct used to modify the chromosomal rpoN. PCR amplification of rpoN
from PAO1 was cloned into the suicide vector, pEX100T, and the gentamicin cassette,

aacC1, digested out of pUCGM1 was inserted into the unique PstI site of rpoN. The
construct, pJHK25, was conjugated into PAO1 and JK159. Merodiploids were selected
using carbenicillin, and eventually, total gene replacement was generated using
gentamicin (selective marker) and sucrose (counterselective marker). The desired
double recombinant strains were gentamicin and sucrose resistant, and carbenicillin
sensitive. These were labeled as JK229 (PAO rpoN::Gm) and JK231 (PAO ΔalgB-kinB

rpoN::Gm). These were further verified by PCR amplification of rpoN confirming the
presence of the gentamicin cassette (Figure 19C).
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Figure 18. Construction of PAO ΔalgB-kinB algT::Gm (JK215) mutant. A.
Illustration of the mechanism used to develop an algT::Gm mutant. Phage
transduction was used to mobilize the algT::Gm mutation from a lab strain, PAO
algT::Gm, to JK159. Gentamicin was used to select for gene replacement. B. PCR
amplification of algT to verify gentamicin cassette insertion for each mutant. The two
control strains, PAO1 and PAO algT::Gm, showed amplicons at 1 kb and 2 kb,
respectively. Both candidates contained gentamicin in their chromosomal algT gene (2
kb).
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Figure 19. Construction of PAO rpoN::Gm (JK229) and PAO ΔalgB-kinB
rpoN::Gm (JK231) mutants. A. Diagram of genetic construction used to modify
the chromosomal rpoN gene. PCR amplified rpoN from PAO1 was cloned into
pEX100T. The gentamicin cassette, aacC1, was digested out of pUCGM1 with PstI and
inserted into rpoN at the same unique site. This generated pJHK25. B. Illustration of
allelic exchange. The construct, pJHK25, was mobilized to PAO1 and JK159 via
triparental conjugation. Eventually, gentamicin resistance was used to select for
double recombination between rpoN::Gm on the plasmid and chromosomal rpoN. C.
PCR amplification of rpoN was used to verify the gentamicin insertion. The control,
PAO1, with no gentamicin had an amplicon at 1.5 kb. The two mutant candidates,
JK229, and JK231, had the gentamicin cassette inserted in rpoN with a product size of
2.5 kb.
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Insertional mutation rendered sigma 54 (RpoN) nonfunctional. Since
the σ54 (RpoN) mutation was only an insertional one occurring two-thirds of the way
down the gene, I needed to verify that the mutant sigma factor was rendered
nonfunctional. This was accomplished by performing the twitching motility assay.
Twitching motility is a phenomenon defined by the movement of bacteria across a solid
surface mediated by the extension and retraction of type-4 fimbriae or pili. The major
structural component of pili is PilA protein, which is dependent upon sigma 54 for its
transcription (51). Therefore, a nonfunctional sigma 54 would result in no transcription
of pilA, and subsequently no pili formation and no twitching motility. The twitching
motility assay allows for visualization of the bacterial movement between the interface
of the agar and the plate. Three Pseudomonas strains (PAO1; JK229, PAO rpoN::Gm;
and JK231, PAO ΔalgB-kinB rpoN::Gm) were used to inoculate a plate of thinly poured
LB agar. A needle was used to perpendicularly stab the agar down to the plate, and
the bacteria were incubated overnight at 37°C. The agar was wicked dry with
Whatman #1 filter paper and the bacteria were stained with 0.5% coomassie brilliant
blue R250. Figure 20 shows the results of this assay. PAO1, the wild type control, was
positive for twitching motility displaying radiated movement out from the site of
inoculation. However, both σ54 (RpoN) mutants did not show any twitching motility.
Staining was only observed with bacteria at the original stab site. Therefore, these
results confirm that the insertional mutation is sufficient in rendering sigma 54
nonfunctional.
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Figure 20. Twitching motility assay. Sigma 54 (RpoN) mutant strains were used
to stab inoculate a thin plate of LB agar. They were incubated overnight at 37°C and
stained with 0.5% coomassie. Twitching motility is observed for the control, PAO1,
with bacterial movement radiated out from the inoculation site. Both mutants did not
display movement away from the stab site indicating a nonfunctional sigma 54.

118

119
Sigma 54 (RpoN) insertional mutation did not affect alginate
production in PDO300. It was previously shown in our lab that a σ54 (RpoN)
mutation did not alter alginate production in a mucA22 strain. However, later it was
found that this σ54 (RpoN) mutation was real. Therefore, after constructing the

rpoN::Gm variant and verifying the sigma factor as nonfunctional, I determined whether
this mutation would have an effect on the production of alginate in PDO300 (PAO

mucA22). Initial attempts to construct the PDO300 rpoN::Gm mutant via phage
transduction and triparental conjugation were unsuccessful. The generalized
transduction method proved to be futile because it was later found that the phage,
F116L, required pili for adsorption (8). This explained my inability to obtain lysates
from PAO rpoN::Gm and confirmed that RpoN was not functional. Another strategy
was developed so that phage transduction could be productive (Figure 21). The
process involved complementation of JK229 with wild type RpoN added in trans. PCR
amplified rpoN was cloned into the pJHK21 vector generating pJHK30 (Figure 21A) and
electroporated into JK229. Carbenicillin resistant candidates were selected and were
infected with F116L phage. This time lysates were successfully generated indicating
complementation of the mutant RpoN variant by wild type allowing for the construction
of pili. The lysates were used to transduce PDO300 and gentamicin was used to select
for allelic exchange (Figure 21B). The mutants (JK260) were confirmed via PCR
amplification of rpoN (data not shown). It was determined based on plate morphology
that the RpoN mutation did not affect alginate production of PDO300. The colonies
were still mucoid and at similar levels compared to the parent strain (data not shown).
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Figure 21. Construction of PDO300 rpoN::Gm (JK260). A. Illustration of
plasmid used to complement JK229. Wild type rpoN from PAO1 was PCR amplified
and cloned into pJHK21 (pTrcHisA + mSF) creating pJHK30. This construct was
electroporated into JK229. Plaques were formed after infection with F116L indicating
complementation by wild type RpoN. B. Mechanism used to construct JK260.
PDO300 was transduced with F116L phage carrying lysates of JK229 (pJHK30).
Genatmicin was used to select for double recombinants and verified via PCR.
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Mutagenesis of rpoN eliminated alginate synthesis under His-AlgBE125K
control while mutation of algT promoted its production
In order to determine which of the two sigma factors was involved in the
alginate production induced by His-AlgBE125K, pJHK13 (His-AlgBwt) and pJHK20 (HisAlgBE125K) were electroporated into the sigma factor triple mutants, JK215, PAO ΔalgB-

kinB algT::Gm, and JK231, PAO ΔalgB-kinB rpoN::Gm, and candidates were selected for
carbenicillin resistance. Alginate production was difficult to assess based on plate
morphology because both sigma factor mutations generated small and punctate
colonies. Therefore, the amount of alginate produced was determined using the uronic
acid assay. This assay was performed as previously described. The micrograms of
uronic acid were normalized against the cell pellet weight of each strain and graphed.
The results for the sigma factor triple mutant strains carrying pJHK20 (His-AlgBE125K) are
presented in Figure 22. Both of these strains were compared to the control strain,
JK159 (pJHK20), which was shown earlier in Chapter 3 measuring at 2,667.96 ± 609.55
µg of uronic acid/g cell pellet. This was similar to the amount of uronic acid produced
by JK215 (pJHK20), 3,123.19 ± 1012.25 µg/g, which was slightly more, but not
significantly different from control. The strain with the σ54 (RpoN) mutation carrying
the His-AlgBE125K variant, showed a significant decrease in the amount of uronic acid
generated, 158.86 ± 67.02 µg/g, compared to JK159 (pJHK20). This was a 17-fold
decrease compared to JK159 (pJHK20) indicating an inhibition in alginate production
with the loss of sigma 54.
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In Figure 23, the uronic acid amounts secreted by the sigma factor mutants with
pJHK13 compared to the control strain, JK159 (pJHK13), are shown. The level of uronic
acid generated by the control was similar to background levels of PAO1 as previously
determined (437.59 ± 190.24 µg/g). This was also true for JK231 (pJHK13) measuring
at 261.39 ± 153.72 µg/g. Surprisingly, the σ22 (AlgT) mutation stimulated a significant
amount of alginate, 2,069.03 ± 749.65 µg/g, compared to JK159 (pJHK13), and was
similar to the levels seen for the algB-kinB deletion strain with the His-AlgBE125K
construct. Therefore, His-Algwt was able to induce alginate production in the absence of
sigma 22, however, this induction was not present when sigma 54 was rendered
nonfunctional.

Mutagenesis of algT promoted transcriptional activation of algD operon
whereas no increased activity was seen for the sigma 54 (RpoN) mutant
compared to PAO1
After alginate levels were assessed for each sigma factor triple mutant strain
with either His-AlgBwt or His-AlgBE125K, I determined whether the changes observed
from the uronic acid assay occurred at the transcriptional level. Both RT PCR and real
time RT PCR were conducted to look at transcript levels of algD (target) compared to

omlA (internal control). Total RNA isolated from Pseudomonas strains grown to late log
phase was used in these two methods as described beforehand. RT PCR results of
JK215 and JK231 carrying the His-AlgBE125K construct are presented in Figure 24. The
reverse transcription control (No RT) gel did not display any PCR amplified bands
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Figure 22. Uronic acid assay results for JK159 and the two sigma factor
triple mutant strains (JK215 and JK231) carrying pJHK20 (His-AlgBE125K).
Levels of uronic acid produced by JK215 (pJHK20) were similar to the control JK159
(pJHK20) strain. However, the RpoN mutation inhibited alginate production
significantly compared to the control strain. NM and M represent nonmucoid and
mucoid phenotypes, respectively.
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Figure 23. Uronic acid assay results for JK159 and the two sigma factor
triple mutant strains (JK215 and JK231) carrying pJHK13 (His-AlgBwt).
Levels of uronic acid produced by JK231 (pJHK13) were similar to the control JK159
(pJHK13) strain. Surprisingly, the AlgT mutation induced production of alginate
significantly compared to the control strain. NM and M represent nonmucoid and
mucoid phenotypes, respectively.
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Figure 24. RT PCR results for JK159, JK215, JK231 strains carrying pJHK20
(His-AlgBE125K). No RT control was absent of any PCR product bands indicating no
genomic DNA contamination, and the omlA transcripts were similar for all
Pseudomonas strains. JK159 (pJHK20) and JK215 (pJHK20) presented with the most
amount of algD transcipts, while JK231 (pJHK20) had the least amount of transcript,
which was even less than background levels seen by PAO1.
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indicating the absence of genomic DNA contamination. The internal control gene,

omlA, exhibited bands that appeared relatively similar for each strain as expected. For
the target gene, algD, PAO1 had background levels of transcript. Both JK159 (pJHK20)
and JK215 (pJHK20) showed similar levels of algD that were obviously elevated
compared to PAO1 corresponding to the uronic acid assay results. The σ54 (RpoN)
triple mutant with His-AlgBE125K had the least amount of algD transcript, which was even
less than the background levels seen in PAO1. This was also observed for the uronic
acid assay with JK231 (pJHK20) measuring at 158.86 ± 67.02 µg/g, which was
significantly less (p ≤ 0.01) than PAO1, 508.89 ± 144.52 µg/g. The real time RT PCR
data also confirmed these results (Figure 25). JK159 (pJHK20) had an 11-fold increase
in algD transcript over wild type PAO1 and the σ22 (AlgT) triple mutant carrying pJHK20
was similar with a 9-fold increase. Both levels were significantly greater than PAO1.
JK231 (pJHK20) displayed a slight decrease in algD transcript levels, but this was not
significant compared to the wild type strain.
The RT PCR data for the strains containing pJHK13 (His-AlgBwt) also
corresponded to the uronic acid data above (Figure 26). The controls were as expected
with the reverse transcription control displaying no PCR product bands, and the omlA
transcripts at similar levels for each of the Pseudomonas strains. The transcript
amounts of algD were equivalent for PAO1 and JK231 (pJHK13). There was a marginal
increase in algD for JK159 (pJHK13), which had been observed before in Chapter 3.
The σ22 (AlgT) triple mutant with His-AlgBwt had the highest level of algD transcript. In
Figure 27, the fold changes in algD expression compared to PAO1 were determined by
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real time RT PCR. There was a significant 3-fold increase in algD transcript for JK159
(pJHK13) compared to the wild type strain, which as stated previously was not enough
to induce alginate production. The σ54 (RpoN) triple mutant carrying His-AlgBwt had no
fold change in algD compared to PAO1. However, as shown with the uronic acid assay,
there was a 13-fold increase in algD expression for JK231 (pJHK13), which was
significantly greater than PAO1.
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Figure 25. Real time RT PCR results for JK159, JK215, and JK231 strains
carrying pJHK20 (His-AlgBE125K). JK159 (pJHK20) showed an 11-fold increase in
algD expression, which was similar to the 9-fold increase observed by JK215 (pJHK20).
Both were significant compared to no change. JK231 (pJHK20) had a marginal
decrease in algD transcript compared to PAO1, which was not significant.

133

134

Figure 26. RT PCR results for JK159, JK215, and JK231 strains carrying
pJHK13 (His-AlgBwt). The controls were as expected with the reverse transcription
control displaying no amplicons and the omlA internal control showing equivalent
levels for each strain. JK159 (pJHK13) had a slightly increased amount of algD
transcript compared to PAO1 and JK231 (pJHK13) showed a similar amount to wild
type. A dramatic increase in algD levels was seen for JK215 (pJHK13).
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Figure 27. Real time RT PCR results for JK159, JK215, and JK231 strains
carrying pJHK13 (His-AlgBwt). A 3-fold significant increase in algD expression was
observed for JK159 (pJHK13), which had been seen previously but was not enough to
generate alginate. No fold change was seen with JK231 (pJHK13). JK215 (pJHK13)
had a 13-fold increase in algD transcript, which was significant.
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Discussion
After it had been established that the induction of alginate by His-AlgBE125K
occurred at the transcriptional level, I investigated the possible sigma factor required in
the transcriptional process. There were only two sigma factors that were considered to
be involved with the activation of the algD operon, σ22 (AlgT) and σ54 (RpoN). Focus
was directed towards these two regulators because σ22 (AlgT) has a significant role in
alginate production and σ54 (RpoN) is generally associated with the NtrC family of
response regulators. In order to determine the relevant sigma factor, I generated
mutations of each in JK159 constructing triple mutant strains. The algT::Gm mutation
was easily mobilized from a lab strain, PAO algT::Gm, to the algB-kinB deletion strain
via phage transduction creating JK215. The rpoN::Gm mutation had to be
reconstructed since the rpoN insertional mutant in the lab collection was not real. Once
this mutation was used to generate PAO rpoN::Gm, JK229, and PAO ΔalgB-kinB

rpoN::Gm, JK231, I confirmed that the sigma factor was no longer functional via the
twitching motility assay. I also verified that σ54 (RpoN) was not required for alginate
production in a strain of Pseudomonas with a deregulated σ22 (AlgT), PDO300. Once
the sigma factor triple mutants were made, I electroporated pJHK13 (His-AlgBwt) and
pJHK20 (His-AlgBE125K) into each of these strains. Uronic acid assays were used to
assess levels of alginate produced. For the strains with pJHK20, mutation of σ22 (AlgT)
had no effect on the amount of alginate induced by His-AlgBE125K, showing levels that
were similar to JK159 (pJHK20). However, the σ54 (RpoN) mutation greatly inhibited
alginate production at significantly less than background quantities produced by PAO1.
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These results were also seen at the transcript level. JK159 (pJHK20) had an 11-fold
increase in algD expression, as shown previously, and the σ22 (AlgT) triple mutant with
pJHK20 had a 9-fold increase, which was similar. Both were significantly greater than
the algD levels measured for PAO1. The strain with the σ54 (RpoN) mutation had a
slight decrease in algD transcript, which was not significantly different from the wild
type strain. Based on these data, sigma 54 is involved in the transcriptional activation
of alginate in addition to His-AlgBE125K. This further supports the notion that HisAlgBE125K is an overactive mutant, since the activator must function as a response
regulator belonging to the NtrC family if sigma 54 is required for the transcription of the

algD operon.
Introduction of pJHK13 to the sigma factor triple mutants generated unexpected
and interesting results. The RpoN mutation had no effect on uronic acid levels
compared to JK159 (pJHK13). Both produced background amounts, which were similar
to PAO1. Surprisingly, mutation of AlgT allowed for a significant induction of alginate,
which was similar to levels produced by JK159 (pJHK20). RT PCR and real time RT PCR
showed comparable results. There was no change in algD expression for the RpoN
triple mutant with pJHK13, and a 13-fold increase in expression for the AlgT triple
mutant, which was significant. These data suggest that RpoN is responsible for the
activation of the algD operon since its mutation prevents alginate production. The data
also suggest that AlgT acts as an inhibitor of RpoN because its presence does not allow
for the induction of alginate, but its absence does. This concept has been proposed
earlier with published evidence showing competition between AlgT and RpoN for
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binding to the algD promoter (10). Additional research also supports AlgT as a
dominant sigma factor since mutations of proteins involved in two-component
regulation including phosphorylation mutants of AlgB, deletion of KinB (45), and
inactivation of RpoN shows no effect on alginate production in a mucA22 strain.
Therefore, AlgT binding to the algD promoter could be favored over RpoN, and even
under tight regulation, AlgT could still bind to the promoter preventing alginate
activation by RpoN. The reason for the lack of alginate induction when only AlgT is
present is probably because the mechanism involved in algD activation requires multiple
proteins. Copious levels of the exopolysaccharide are only seen when AlgT is
deregulated and can induce transcription of the other proteins that bound the algD
promoter. However, the mechanism of two-component regulation is much simpler
involving KinB, AlgB, and RpoN. Although KinB is not present to phosphorylate AlgB,
published research has shown that regulators can be phosphorylated by small
phosphodonors as well as other kinases, but the rate of phosphorylation is much slower
(17, 34, 75). Expression from pJHK13 is leaky increasing the levels of His-AlgBwt
protein making it feasible for some to become phosphorylated allowing for algD
transcriptional activation in the presence of RpoN when uninhibited by AlgT.

Chapter 5: Characterization of the overactive His-AlgBE125K protein using
biochemical methods

Introduction
Data obtained thus far has demonstrated His-AlgBE125K to be an overactive
mutant inducing alginate production at the transcriptional level in association with
sigma 54. Characterization of the mutant was assessed to determine a possible
mechanism allowing for overactive transcriptional activation. Biochemical assays were
performed to investigate the DNA binding ability of His-AlgBE125K compared to His-AlgBwt
and the ATPase activity of the mutant compared to wild type. DNA binding by AlgB has
acquired a reputation of being difficult to demonstrate in vitro. One recent paper
published electrophoretic mobility shift assay (EMSA) data studying AlgB binding to the

algD promoter. Shifted bands, an indication of binding, were never seen at
physiological pH or at acidic pH below the pI value of AlgB. Instead, aggregation
occurred in the wells at the acidic pH with loss of intensity of the free DNA bands. As
support for DNA binding by AlgB, a graph was included displaying the increased loss of
free DNA with increased concentration of AlgB protein (43). Based on the difficulty
seen by wild type AlgB for DNA binding, it was hypothesized that His-AlgBE125K could
bind DNA better than wild type resulting in the overactivation of the algD operon. The
ATPase activity was also assessed because homologues of AlgB including NtrC and DctD
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have shown elevated ATP hydrolysis by the overactive mutant variants of each
regulator compared to the wild type forms (4, 41). Therefore, we hypothesized that
His-AlgBE125K would also exhibit elevated levels of ATPase activity compared to HisAlgBwt resulting in the activation of the alginate operon.
Optimization of the induction and purification of His-AlgB protein
variants. Approximately 1 mg/mL of purified protein was desired for the biochemical
assays, I first determined the parameters for induction of the His-tagged constructs.
Two induction experiments were performed to ascertain the concentration of inducer
(IPTG), and the stage of growth at which IPTG was added that would generate the
most amount of each His-AlgB protein. In the first experiment four different
concentrations of IPTG (0.5, 1, 3, and 5 mM final) were added to strains of E. coli
carrying one of the following: pTrcHisA (empty vector), pJHK12 (His-AlgBwt), pJHK17
(His-AlgBD105K), or pJHK18 (His-AlgBE125K). Each strain was grown to an OD600 of 0.5
and induced with one of the four IPTG concentrations. Cells were harvested at 5 and
24 hours post induction, and the cell lysates were subjected to Western blot analysis
screened with anti-6X His antibody. These results are presented in Figure 28. The Histagged wild type and mutant AlgB proteins migrated at the expected 52 kDa in size.
The strain carrying empty vector (pTrcHisA) showed no bands at 52 kDa. There were
also no His-tagged protein bands displayed by any of the bacteria prior to induction
indicating an efficient control of expression in E. coli. The strain with His-AlgBwt
produced the greatest amount of protein in the presence of 5 mM of IPTG for 24 hours,
and the one carrying His-AlgBE125K showed maximal expression with 0.5 mM of IPTG for
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Figure 28. Western blot analysis of cell lysates induced with various
concentrations of IPTG. E. coli strains carrying pTrcHisA (empty vector), pJHK12
(His-AlgBwt), pJHK17 (His-AlgBD105K), and pJHK18 (His-AlgBE125K) were grown to OD600
of 0.5. These were induced with 0.5, 1, 3, and 5 mM IPTG and cells were harvested 5
and 24 hours post induction. Lysates were run on a Western blot and screened with
anti-6X His antibody. Uninduced (unind) samples were also collected for each strain.
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24 hours. However, all of the IPTG concentrations induced relatively equivalent levels
of protein for His-AlgBE125K. The E. coli strain with His-AlgBD105K did not express a lot of
induced protein. The proteins appeared to be unstable and were barely detectable on
the Western blot.
For the second experiment, a single concentration of IPTG (1 mM final) was
added to the same strains listed in the first experiment at early (OD600 of 0.2), middle
(OD600 of 0.5), and late (OD600 of 0.8) log phases. The cultures were induced for 5 and
24 hours and the cells were subsequently harvested. Lysates were examined via
Western blot analysis and screened with anti-6X His antibody. Figure 29 displays the
Western blot results. The empty vector control exhibited no 52 kDa bands before or
after induction as expected. Both His-AlgBwt and His-AlgBE125K displayed the most
protein when the strains were induced during early log phase (OD600 of 0.2). Once
again, the bacteria carrying His-AlgBD105K did not show much induced protein at any of
the growth phases suggesting protein instability. It was decided after assessing the
data from both of these experiments that 5 mM of IPTG would be used for induction
and that cultures would be induced at early log phase (OD600 of 0.2) for 24 hours. It
was also decided that His-AlgBD105K would not be added to the biochemical assays since
the protein was unstable.
Once the induction process was optimized, protein isolation was accomplished
using the His•Bind resin (Novagen) method. The protocol was followed as written by
the manufacturer, and the His-tagged wild type and mutant AlgB proteins were eluted
using the 1X elution buffer prepared as dictated by the protocol. Unfortunately, the
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Figure 29. Western blot analysis of cell lysates induced at early (OD600 of
0.2), middle (OD600 of 0.5), and late (OD600 of 0.8) log phases with 1 mM of
IPTG. E. coli strains carrying pTrcHisA (empty vector), pJHK12 (His-AlgBwt), pJHK17
(His-AlgBD105K), and pJHK18 (His-AlgBE125K) were grown to the various log phases and
were induced with 1 mM IPTG. Cells were harvested 5 and 24 hours post induction.
Lysates were run on a Western blot and screened with anti-6X His antibody.
Uninduced (unind) samples were also collected for each strain.
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eluted proteins for both variants flocculated in the buffer regardless of storage
temperature, 4°C or room temperature. In order to prevent aggregation, changes were
made to one of the following: the dialysis buffer, the induction conditions, and the
elution buffer. The first modification attempted to resolubilize the aggregated proteins
during dialysis. Initially, the eluted His-AlgB proteins were transferred to a Slide-ALyzer dialysis cassette, 10k MWCO (Pierce) and dialyzed in 1X TBS. Based on a
published protocol, two amino acids, 50 mM glutamic acid and 50 mM arginine, were
added to the 1X TBS dialysis buffer, which was expected to lead to resolubilization (30).
However, the eluted proteins remained aggregated in the dialysis cassette. The second
change was performed to reduce the total amount of protein induced from each strain,
since the induction process was optimized to allow for the maximum amount of protein
produced. The first adjustment to this process was to reduce the final concentration of
IPTG from 5 mM to 3 mM for the E. coli strain carrying pJHK12 (His-AlgBwt) because it
produced more protein than the strain with pJHK18 (His-AlgBE125K). The second
adjustment reduced the induction time to 3 hours instead of 24 hours. Cells were
harvested and proteins were isolated, but, unfortunately, these modifications did not
prevent aggregation following elution. The final changes were made to the elution
buffer since flocculation only occurred after elution. The original elution buffer
contained 20 mM Tris-HCl, pH 7.9; 1 M imidazole; and 0.5 M NaCl. Two modified
buffers were made: 1) an increased concentration of NaCl (1 M) and 2) a decreased
concentration of imidazole (0.5 M). Both were used to elute proteins from the His•Bind
columns and the buffer with 0.5 M imidazole did not have aggregated proteins. In
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order to determine which elution fractions contained the 52 kDa His-AlgB proteins, six 1
mL eluted aliquots were run on an SDS-PAGE gel and stained with coomassie (Figure
30). Both His-tagged wild type and mutant AlgB proteins were found in the first three 1
mL elutions. Therefore, the ultimate induction method described in detail in the
Materials and Methods section (Chapter 2) was used to generate the His-AlgB proteins,
which were eluted with 3 mL of modified elution buffer. Finally, the buffer was
exchanged with 1X TBS and the proteins were concentrated using the Amicon Ultra-4
filter units. The BCA kit was used to quantitate the protein amounts, which ranged
from 0.9-2 mg/mL.

Binding of His-AlgBE125K to the algD promoter region
Once approximately 1 mg/mL of soluble His-tagged wild type and mutant AlgB
proteins were obtained, I determined whether His-AlgBE125K had a higher affinity for
DNA than His-AlgBwt via electrophoretic mobility shift assay (EMSA). This assay was
performed using a nonradioactive approach. The specific DNA probe (-324 to –24;
PalgD300) and nonspecific DNA probe (+1 to +367; PalgDLeader) were designed based on
ones that were previously published (43). Figure 31A illustrates the location of the
probes within the algD promoter. These DNA fragments were biotin labeled on the 3’
end using a biotin labeling kit (Pierce). The labeling efficiencies were determined
comparing unlabeled and biotin labeled controls that were hand spotted onto a nylon
membrane. An example of a dot blot is shown in Figure 31B. Efficiencies ranged from
20-60% depending on the probe. Binding reactions were prepared after the DNA
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Figure 30. Purification of His-tagged wild type and mutant AlgB proteins.
After isolation of His-AlgBwt and His-AlgBE125K using the His•bind resin, the proteins
were eluted off the columns with the modified elute buffer in six 1mL elution fractions.
These were subjected to SDS-PAGE and stained with coomassie blue.
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Figure 31. Specific and nonspecific DNA probes for EMSA. A. Location of the
two probes mapped to the algD promoter. The specific probe was 300 bp upstream of
the +1 site and the nonspecific probe was the leader strand. B. An example of a
labeling efficiency dot blot. DNA probes labeled on the 3’ end with biotin were
assessed comparing unlabeled and biotin labeled controls.

153

154
probes were labeled combining various concentrations of proteins (100 nM, 1, 5, and 10
µM) to the biotin labeled specific and nonspecific DNA fragments. The His-AlgB variants
used were His-AlgBwt, His-AlgBE125K, and His-AlgBR442E (helix-turn-helix, HTH, mutant).
The His-AlgBR442E is the DNA binding mutant control and therefore will not form any
complexes with the DNA probes. The binding reactions were incubated for 20 minutes
at room temperature and loaded onto a 5% polyacrylamide TBE gel. The samples were
transferred to a positively charged nylon membrane and the DNA was cross-linked to
the membrane via UV exposure. The blot was developed using a chemiluminesence kit
(Pierce) and exposed to x-ray film. The EMSA blot with the nonspecific leader probe
(PalgDLeader) showed only bands representing free DNA (Figure 32). There were no
DNA/protein complexes formed indicating the absence of nonspecific binding between
the His-AlgB constructs and DNA. The blot containing binding reactions with specific
DNA probe (PalgD300) produced no shifted binding bands for the helix-turn-helix AlgB
mutant at any of the protein concentrations as expected (Figure 33). However, shifted
bands were observed for His-AlgBwt at 5 and 10 µM, and for His-AlgBE125K at 10 µM.
There was an obvious decrease in the level of free DNA for the latter protein, but the
shifted band, although present, was barely detectable.
Even though I was able to show in vitro binding of His-AlgB to DNA, a large
amount of protein was needed to accomplish this effect. Two approaches were
pursued for optimizing binding conditions that would feasibly decrease the amount of
protein needed for binding to occur. The first approach involved redesigning the
specific DNA probe. Both NtrC and DctD, homologues of AlgB, had been established to
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Figure 32. EMSA blot of His-tagged wild type and mutant AlgB proteins
with Biotin labeled nonspecific DNA probe. Binding reactions were prepared
with different concentrations (0.1, 1, 5, and 10 µM) of His-AlgBwt, His-AlgBE125K, and
His-AlgBR442E (HTH mutant). These were combined with the biotin labeled nonspecific
PalgDLeader probe. The location of the probe is mapped in the algD promoter shown
below the EMSA blot. The binding reactions were incubated for 20 minutes at room
temperature and eventually observed using chemiluminescence. Position of unbound
DNA probe is indicated on the left.
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Figure 33. EMSA blot of His-tagged wild type and mutant AlgB proteins
with Biotin labeled specific DNA probe. Binding reactions were prepared with
different concentrations (1, 5, 10 µM) of His-AlgBwt, His-AlgBE125K, and His-AlgBR442E
(HTH mutant). These were combined with the biotin labeled specific PalgD300 probe.
The location of the probe is mapped in the algD promoter shown below the EMSA blot.
The binding reactions were incubated for 20 minutes at room temperature and
eventually observed using chemiluminescence. Positions of unbound DNA probe and
AlgB/DNA complex are indicated on the left.
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bind to two sites within promoter regions controlled by these two regulators. Binding
was also determined to be cooperative at both of these sites (40, 62). AlgB could also
have two binding sites within the algD promoter. The specific probe used in the binding
reactions above only encompassed 300 bp of the upstream region from the +1 site and
may not have incorporated a second binding site. A new specific probe was generated
including the entire region upstream of the +1 site resulting in PalgD534 (Figure 34A).
This was biotin labeled as previously described and combined with 0.1, 1, 5, and 10 µM
of the same His-AlgB proteins listed above. The result from this assay is shown in
Figure 34B. As expected, the His-AlgB DNA binding mutant did not show a shifted band
at any of the protein concentrations. Unfortunately, no shifted band was seen for HisAlgBwt or His-AlgBE125K either. The second approach involved changing conditions to the
binding reaction. The original binding reaction occurred at a neutral pH of 7.5 and the
reaction buffer contained 50 mM KCl with no salmon sperm DNA. The new binding
reactions contained either 10 or 50 mM KCl with or without 0.1 µg/µL of salmon sperm
DNA at pH 6.5, 7.5, and 8.5. All of these reactions were performed with 50 and 100 nM
of the three different His-AlgB variants in the presence of labeled specific (PalgD300) and
nonspecific (PalgDLeader) probes. Unfortunately, none of these changes resulted in AlgB
binding to DNA. An example of one of these blots is shown in Figure 35.
Even though attempts to optimize binding conditions were unsuccessful, protein
binding to PalgD300 had still been demonstrated for His-AlgBwt and His-AlgBE125K.
Competition EMSAs were performed to verify binding specificity to the PalgD300 probe.
Initial efforts added unlabeled PalgD300 and unlabeled PalgDLeader in concentrations 5,
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Figure 34. EMSA blot of His-tagged wild type and mutant AlgB proteins
with redesigned Biotin labeled specific DNA probe. A. New specific DNA probe,
PalgD534, mapped to the algD promoter. B. Binding reactions were prepared with
different concentrations (0.1, 1, 5, 10 µM) of His-AlgBwt, His-AlgBE125K, and HisAlgBR442E (HTH mutant). These were combined with the biotin labeled specific
PalgD534 probe. The binding reactions were incubated for 20 minutes at room
temperature and eventually observed using chemiluminescence. Position of unbound
DNA probe is indicated on the left.
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Figure 35. EMSA blot representing one of the changes to the binding
conditions. Binding reactions were performed under three different pH conditions
(6.5, 7.5, and 8.5) with 10 or 50 mM KCl, and with or without 0.1 µg/µL of salmon
sperm. Biotin labeled PalgD300 and PalgDLeader (indicated below) were combined with
50 and 100 nM of His-tagged wild type and mutant AlgB proteins. Positions of
unbound DNA probes are indicated on the left and right.
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25, 50, 100, and 200 fold more than the biotin labeled specific probe (PalgD300). No
competition was seen between the unlabeled specific probe with the labeled one and
the shifted bands remained. Subsequently, it was determined that the ratio of biotin
labeled PalgD300 to protein was extremely small. There was a significantly greater
amount of protein compared to DNA. In order to see any competition between the
labeled and unlabeled DNA probes for binding to His-AlgBwt and His-AlgBE125K, I needed
to increase the level of total DNA thereby raising the DNA to protein ratio. Multiple PCR
reactions were performed to increase the quantity of PalgD300 and PalgDLeader to final
concentrations of 4.33 and 3.77 µM, respectively. Unfortunately, labeling larger
quantities of DNA probe with biotin was unsuccessful. The competition assays were
performed by combining 5 µM His-AlgBwt or 10 µM His-AlgBE125K with a constant amount
of biotin labeled PalgD300 probe and an increasing amount of unlabeled PalgD300 or
unlabeled PalgDLeader probe. The ratios of total DNA to protein used for the competition
EMSAs were 1:10, 1:15, 1:20, 1:50, 1:100, 1:500, and 1:1000. Competition EMSA with
unlabeled PalgDLeader is shown in Figure 36A. The unlabeled nonspecific DNA probe was
not able to compete with biotin labeled PalgD300 bound to His-AlgBwt or His-AlgBE125K.
Free DNA bands were visible for the His-AlgB mutant but they were not nearly at the
level of the no protein control. Also, no shifted bands were observed for the HisAlgBE125K protein, however, overexposure of the EMSA blot revealed smearing at the top
of the gel, which was absent for the wild type protein (Figure 36B). Competition was
seen when increasing amounts of unlabeled PalgD300 were added to the binding
reactions (Figure 37A). For His-AlgBwt, the intensity of the shifted bands decreased
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Figure 36. Competition EMSA blot with unlabeled PalgDLeader probe. A.
Binding reactions combined either 5 µM His-AlgBwt or 10 µM His-AlgBE125K with equal
amounts of biotin labeled PalgD300, and increasing amounts of unlabeled PalgDLeader.
DNA to protein ratios are listed above and increasing DNA concentration is indicated at
the bottom. The position of the unbound probe is indicated at the left. B.
Overexposure of the same blot in A.
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Figure 37. Competition EMSA blot with unlabeled PalgD300 probe. A. Binding
reactions combined either 5 µM His-AlgBwt or 10 µM His-AlgBE125K with equal amounts
of biotin labeled PalgD300, and increasing amounts of unlabeled PalgD300. DNA to
protein ratios are listed above and increasing DNA concentration is indicated at the
bottom. The position of the unbound probe is indicated at the left. B. Overexposure
of the same blot in A.
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while the intensity of the free DNA bands increased. For His-AlgBE125K, shifted bands
were again not detected, but there was an obvious increase in the level of free DNA
bands as the concentration of unlabeled specific probe increased. The smearing effect
was also visible after overexposure of the blot for the mutant protein but not present
for His-AlgBwt.

Effect of His-AlgBE125K on the hydrolysis of ATP
The ATPase activity of the His-AlgB wild type and mutant proteins were assessed
using a radiation based method with radiolabeled ATP, [γ-32P] ATP, and
orthophosphoric acid,

32

Pi. This assay measured the release of inorganic phosphate

after cleavage of ATP. Reactions were prepared combining either 5 µM His-AlgBwt or
His-AlgBE125K with 15 µCi of [γ-32P] ATP in the presence or absence of PalgD300 DNA
fragment. The DNA was added to a set of reactions because research had shown that
NtrC had increased ATPase activity in the presence of DNA containing the two enhancer
sites (4). Two controls were also assembled one with only 15 µCi of [γ-32P] ATP and
the other with only 15 µCi of

32

Pi. The ATPase reactions were incubated at room

temperature for 30 seconds, 1 minute, and 5 minutes. After each time point, the
hydrolysis was stopped with formic acid. Each sample including the controls were
spotted onto PEI-cellulose plates and subjected to ascending chromatography. These
were subsequently analyzed via autoradiography. In the absence of PalgD300 DNA, HisAlgBE125K was able to hydrolyze ATP, and surprisingly, His-AlgBwt also exhibited ATPase
activity releasing

32

Pi (Figure 38A). The cleavage activity increased over time for both
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proteins, and the level of inorganic phosphate released appeared to be equivalent
between the two (Figure 38B). The same results were seen when PalgD300 was added
to the reactions (Figure 39A). The presence of the DNA fragment did not accelerate
the ATP cleavage process. In sum, both proteins exhibited ATPase activity, which
increased over time, and both released similar amounts of
(Figure 39B).

32

Pi at each time point
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Figure 38. Autoradiograph of ATPase activity in the absence of PalgD300. A.
Reactions were assembled combining 5 µM of either His-AlgBwt or His-AlgBE125K with 15
µCi of [γ-32P] ATP. Two controls containing either 15 µCi of [γ-32P] ATP alone or 15
µCi of 32P alone were also prepared. Tubes were incubated at room temperature and
reactions were stopped at 30 sec, 1 min, and 5 min using formic acid. Samples were
spotted onto a PEI-cellulose plate and subjected to ascending chromatography. Plates
were visualized via autoradiography. B. Graph of density values to determine relative
amounts of inorganic phosphate released by each protein over time. The values were
obtained by the autoradiograph in A. Inorganic phosphate control is shown at the 5
min time point.
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Figure 39. Autoradiograph of ATPase activity in the presence of PalgD300.
A. Reactions were assembled combining 5 µM of either His-AlgBwt or His-AlgBE125K
with 15 µCi of [γ-32P] ATP and PalgD300. Two controls containing either 15 µCi of [γ32
P] ATP alone or 15 µCi of 32P alone were also prepared. Tubes were incubated at
room temperature and reactions were stopped at 30 sec, 1 min, and 5 min using
formic acid. Samples were spotted onto a PEI-cellulose plate and subjected to
ascending chromatography. Plates were visualized via autoradiography. B. Graph of
density values to determine relative amounts of inorganic phosphate released by each
protein over time. The values were obtained by the autoradiograph in A. Inorganic
phosphate control is shown at the 5 min time point.
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Discussion
Biochemical assays were performed to understand some of the characteristics of
the overactive His-AlgBE125K mutant. This mutant form of AlgB has been shown to
activate the algD operon in association with sigma 54 producing a significant amount of
alginate. The His-AlgBD105K mutant was shown to be unstable in both E. coli and P.

aeruginosa. No alginate induction was seen by Pseudomonas strains carrying this
mutant AlgB which could be a result of the protein’s instability. Therefore, His-AlgBD105K
protein was not investigated in the biochemical assays. I focused on two properties
that could possibly elucidate the overactive nature of the His-AlgBE125K variant. The first
was to compare the DNA binding ability of His-AlgBE125K to wild type, and the second
was to compare the level of ATPase activity between the mutant and wild type AlgB.
The electrophoretic mobility shift assay, EMSA, was used to determine the effect
of DNA binding by His-AlgBE125K. AlgB has a history of being difficult to demonstrate
binding to DNA in vitro. Only one recent publication includes EMSAs of wild type AlgB.
Although no shifted bands are present in the blots, EMSAs performed at pH 4.3 display
decreasing levels of free DNA with increasing amounts of AlgB, which is not seen with
the DNA binding mutant (43). Since wild type AlgB has such level of difficulty, it was
possible that the mutant, His-AlgBE125K, could bind DNA with a higher affinity than HisAlgBwt, which would allow for increased transcriptional levels of the algD operon. This
would be a novel characteristic because overactive mutants of NtrC and DctD bind DNA
with the same affinity as wild type (62, 72). Based on the EMSA data, I was able to
demonstrate binding of His-AlgBwt to algD promoter DNA at physiological pH 7.5.
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Distinct shifted bands were present with a decrease in the free DNA bands when 5 and
10 µM amounts of protein were added to the binding reaction. A shifted band was also
present for His-AlgBE125K, however, the band was not as strong as the ones seen for
His-AlgBwt. The overactive mutant appears to have a lower DNA binding affinity
compared to wild type since more protein is required for the gel shift to occur. Also,
the presence of a weaker shifted band could indicate an unstable protein/DNA complex
or the formation of aggregated forms unable to enter the gel. The overall binding
affinity for both His-AlgB proteins is very low since a large amount is required to
generate a shift. Attempts to optimize binding conditions were unsuccessful, however,
there still could be a second binding site within the algD promoter. The 534 bp probe
used to address this, might have been too large of a DNA fragment hindering any
binding that would have occurred. Future studies should perform these EMSAs using
smaller DNA fragments starting within the original 300 bp probe moving a few base
pairs upstream at a time. For the competition EMSAs, unlabeled PalgD300 was able to
compete with biotin labeled probe for both proteins, however, a large amount of
unlabeled DNA was required. This same amount of unlabeled PalgDLeader did not
compete with the labeled PalgD300. Again, these data demonstrate the low binding
affinity of the His-AlgB proteins to DNA. Overexposure of the competition EMSA blots
also revealed a smearing effect at the top of the gel for His-AlgBE125K, which was not
present for His-AlgBwt. This again could be the result of unstable protein-DNA
complexes or aggregate formation.
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The ATPase assay was used to determine the level of ATP hydrolysis for HisAlgBE125K compared to His-AlgBwt. Overactive mutants of NtrC and DctD have displayed
a dramatic increase in this activity, which occur at very low levels for inactive wild type
proteins. Furthermore, it has been shown that the addition of DNA containing the
specific binding sites stimulated even more ATP hydrolysis (4, 41). His-AlgBwt and HisAlgBE125K were combined with [γ-32P] ATP in the presence or absence of PalgD300 and
incubated at room temperature for 30 seconds, 1 minute, and 5 minutes. Both proteins
had ATP hydrolytic activity, which occurred rapidly. By 5 minutes, nearly all of the
added [γ-32P] ATP had been cleaved releasing

32

Pi. The addition of PalgD300 did not

stimulate more ATPase activity for the mutant compared to wild type. Surprisingly, HisAlgBwt displayed a similar level of hydrolysis compared to His-AlgBE125K, both measuring
equivalent amounts of liberated

32

Pi at each time point. Intrinsic ATPase activity has

been shown to occur for both DctD and NtrC1, however, the N-terminal domains of
these proteins provide regulation of this activity. Therefore, overactive mutants of
these proteins are generated with the removal of the N-terminus (42, 55). These data
demonstrate AlgB as the first regulator of the NtrC family to display intrinsic ATP
hydrolysis with full-length unphosphorylated protein.

Chapter 6: Partial investigation of additional genes under AlgB control
Introduction
Identification of genes dependent on KinB and AlgB as a two-component system
for their regulation was the focus of this study. Other regulators of the alginate operon
including AlgR and AmrZ have been investigated and found to be involved in the
activation or inhibition of promoters other than PalgD. Investigation of these proteins
not only provides some understanding of the mechanism involved in the regulation of
these genes but also an understanding of the mechanism in the establishment and
maintenance of infection (7, 51, 80, 88). Two methods were employed to identify the
genes regulated by KinB/AlgB. The first involved microarray data previously generated
in our lab and the second utilized the chromatin immunoprecipitation sequencing (ChIPSeq) method. By identifying additional promoters regulated with this two-component
system, a better comprehension of the regulation process would be acquired including
environmental cues stimulating activation, as well as an understanding of the role
KinB/AlgB plays in the survival of Pseudomonas aeruginosa.

Verification of putative AlgB regulated genes based on fold changes observed
via microarray
In order to initially address the role of KinB and AlgB as global regulators of P.

aeruginosa, microarrays were previously performed in triplicate comparing wild type
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PAO1 against PDO401 (PAO algB::Gm) and PDO406 (PAO kinB::Gm). The data from
this assay showed a number of genes ≥5 fold down in the mutants compared to wild
type (p ≤ 0.05) suggesting a dependence upon KinB and AlgB for their expression.
Promoter activity of one gene, PA1183 (dctA), and an operon (PA0603, 0604, 0605, and
0606) were assessed by β-galactosidase assays to verify the microarray data. All of
these genes displayed greater than a 5 fold decrease in both mutant strains, PDO401
and PDO406, compared to PAO1 (Table 2). The regulation of C4-dicarboxylate
transport protein encoded by PA1183 (dctA) in P. aeruginosa had been studied
extensively in Rhizobium and was found to be a two-component system, DctB/DctD.
Since neither of these regulatory proteins was found in the PAO1 genome, KinB/AlgB
could be the system involved in the regulation of dctA. The genes that were found in
the operon encoded proteins that were homologous to those of the spermidine
transport system (PotA, D, B, and C) in E. coli. Spermidine, a polyamine, provides
essential amino acids necessary for cell growth. Therefore, regulation of this operon by
a two-component system sensing the environment for the presence or absence of these
growth factors would be reasonable. The promoter regions of PA1183 and the PA0603
operon were cloned into pSS269 containing a promoterless lacZ to generate pJHK7 and
pJHK8, respectively (Figure 40). Both constructs were conjugated into PAO1, PDO401,
and PDO406. Promoter activity was measured based on the level of cleavage activity
displayed by β-galactosidase correlating to the amount of enzyme transcribed off the
constructs. One hundred microliters of cells from cultures grown to an OD600 of 0.8
were permeabilized with the addition of SDS and chloroform providing access to any
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Figure 40. Construction of the plasmids used for β-galactosidase assays.
PCR amplification of promoter regions to PA1183, and the PA0603 operon were cloned
into pSS269, which contained a promoterless lacZ. Amplification also included 101 bp
of the upstream genes as well as 101 bp of PA1183 and PA0603. The constructs
generated were pJHK7 with PPA1183 and pJHK8 with PPA0603.
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β-galactosidase enzyme present. The substrate, ONPG, was added to the
permeabilized cells, and a start time was recorded. As soon as the mixture turned
yellow indicating the release of ortho-nitrophenol (colored product), sodium carbonate
was added to stop the reaction, and a stop time was recorded. The samples were read
using a spectrophotometer at OD420 and OD550, and the miller units were calculated for
each strain representing the relative activity of each promoter. The results are listed in
Table 3. For the strains with pJHK7 (PA1183 promoter), there was no significant
difference in the amount of miller units for the two mutant strains compared to PAO1.
There was a decrease in promoter activity for the AlgB mutant, PDO401, (4040.98 ±
217.39 MU) compared to PAO1 (5185.64 ± 114.08 MU), but for the KinB mutant,
PDO406 (6098.99 ± 318.38 MU), there was an increase compared to wild type. Strains
carrying pJHK8 (promoter for PA0603 operon) had similar results. PDO401 and PAO1
were essentially the same measuring at 4506.07 ± 422.90 MU and 4925.95 ± 423.37
MU, respectively. However, PDO406 (7356.46 ± 466.19 MU) had a significant increase
in promoter activity compared to PAO1. The KinB mutant strain with either pJHK7 or
pJHK8 had opposite results from those of the microarray, and although, the AlgB
mutant strain showed decreases in promoter activity, they were not significant
compared to wild type.
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Identification of promoter regions bound by AlgB in vivo
An alternative approach to identify genes regulated by KinB and AlgB was the
chromatin immunoprecipitation sequence (ChIP-Seq) assay. A collaborative effort was
made between our lab and Dr. Yuan Gao’s lab in the department of Computer Science
at Virginia Commonwealth University. It was agreed that I would perform the
chromatin immunoprecipitation assay, and his lab would sequence the DNA fragments
from the ChIP assay using the Illumina Genetic Analyzer (Solexa) to determine the
promoters bound to AlgB. The ChIP-Seq method was the best approach for
determining genes directly regulated by AlgB since the ChIP process involved crosslinking the protein to the bound promoter region in vivo. Also, the sequencing method
employed by the Illumina Genetic Analyzer provided higher resolution, less noise, and
more sensitivity because contrary to the microarray chip analysis this process did not
depend on DNA hybridization (60). The Pseudomonas strains used for the ChIP assay
were algB-kinB deletion strains carrying the His-AlgB constructs: JK159 (pJHK13; HisAlgBwt), JK159 (pJHK20; His-AlgBE125K), and JK159 (pJHK28; His-AlgBR442E). Since Histagged wild type and mutant AlgB proteins were used for this study, I decided to utilize
the α-6X His antibody to precipitate out the regulator instead of the AlgB antibody that
was originally chosen for the protocol (43). However, first I needed to determine the
amount of 6X His antibody to use for the assay. This was accomplished by screening
Western blots of Pseudomonas FRD1 lysates with α-AlgB antibody since the amount of
α-6X His antibody used for screening was already known. Based on this experiment, it
was determined that twice as much α-AlgB Ab was needed compared to α-6X His Ab.
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Therefore, for the ChIP assay, 5 µL of α-6X His Ab was used since the original protocol
designated 10 µL of α-AlgB Ab. The ChIP analysis was performed on the three strains
listed above, which is described in detail in the Materials and Methods (Chapter 2), and
the DNA fragments were extracted and retained. PCR amplification of PalgD and
another promoter not regulated by AlgB, Pneg, was done to verify specificity of binding
by the His-AlgB variants. Since AlgB had been shown to bind the algD promoter,
amplification should be seen for strains with His-AlgBwt and His-AlgBE125K, however, the
strain with His-AlgBR442E, the DNA binding mutant, should have no amplicon. For the
negative promoter, there should be no amplification at all, which would confirm the
absence of random DNA fragments that had not completely been removed during the
wash steps. Figure 41 shows the PCR products after amplification of PalgD. The ChIP
assay was performed in two sets for each strain. From this data, PalgD amplified with
bright bands for the strains with His-AlgBwt and His-AlgBE125K. There was also
amplification seen for the AlgB DNA binding mutant, however, the level of product was
significantly less than the other two bands. Amplification of the negative promoter was
also completed resulting in no bands for all strains (data not shown). These DNA
samples were given to Dr. Gao’s Lab for sequencing. Unfortunately, when the lab
assessed DNA fragmentation, it was found that all three samples contained relatively
equivalent amount of total DNA. This was unexpected because the DNA binding mutant
should have had a significantly less amount of total DNA than the other two variants.
Therefore, the ChIP assay needed to be redesigned.
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Figure 41. ChIP analysis. PCR amplification of PalgD was performed on DNA
fragments collected from JK159 (pJHK13), JK159 (pJHK20), and JK159 (pJHK28)
following the ChIP assay. Two sets of samples for each strain were used in the assay.
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There were two changes made to the ChIP protocol. I decided to use a different
negative control strain and a different antibody. The negative control used was the

algB-kinB deletion strain carrying no His-AlgB constructs, JK159. Therefore no
amplification of PalgD should occur with this strain. The new antibody used was the
AlgB antibody because the α-6X His Ab was a polyclonal that bound to multiple proteins
in Pseudomonas. Since the His antibody was commercial, it could not be preabsorbed
for further purification. Unfortunately, the AlgB antibody, also a polyclonal, did not
exhibit high specificity and bound to multiple proteins as well. However, I was able to
increase specificity of this antibody by preabsorption using boiled lysates of JK159. In
order to determine the success of this process, the preabsorbed α-AlgB antibodies were
used to screen Western blots of Pseudomonas cell lysates (Figure 42). Before
preabsorption, multiple bands were visible on the blot. The higher molecular weight
bands were very prominent and the lower ones were faint but still visible. After
preabsorbing the antibody, most of the nonspecific proteins disappeared. The smaller
molecular weight bands were no longer visible and the larger molecular weight bands
were nearly gone. It was obvious now that JK159 strain did not have any AlgB protein,
and that the other two strains did since AlgB was the only protein with the strongest
band at the correct molecular weight. For the ChIP assay, I used two different amounts
of JK159 lysates to preabsorb α-AlgB Ab. The first used the same volume ratio as the
one used to the screen the Western blots, and the second used a more stringent
method increasing the amount of lysed cells. These were added to the ChIP assay and
the DNA fragments collected were PCR amplified. Once again, amplification of PalgD

190
was seen for all three strains, which included the new negative control (Figure 43).
There was no amplification of the negative promoter for the three strains indicating the
absence of random DNA fragments in the samples.
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Figure 42. Western blot analysis of Pseudomonas cell lysates using
preabsorbed and not preabsorbed α-AlgB Ab. The strains used are listed in the
table. The blot on the left was screened with unaltered α-AlgB Ab and the blot on the
right was screened with preabsorbed antibody. His-AlgB has a molecular weight of 52
kDa.
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Figure 43. ChIP analysis after using preabsorbed α-AlgB Ab. PCR
amplification of the negative promoter, Pneg, (on left), and PalgD (on right) was done
following the ChIP assay. Again two sets for each strain was used for the assay.
Lanes 2 and 10 are PCR controls amplified from PAO1.
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Discussion
The focus of this research was to explore KinB/AlgB as global regulators in

Pseudomonas aeruginosa and to identify the genes that were directly regulated by
these two proteins. I believed that by identifying the genes under KinB/AlgB control
would not only provide an understanding of the regulation process involved but also an
understanding of the role this two-component system contributed to P. aeruginosa.
The initial attempt to identify KinB/AlgB regulated genes was through microarray. A
number of genes were found to be greater than five fold down in both the AlgB and
KinB mutant strains, PDO401 and PDO406, respectively, compared to PAO1. Five genes
were chosen to assess promoter activity and to verify the results seen by microarray.
The first was PA1183, which encoded a protein homologous to DctA, a C4-dicarboxylate
transporter protein. The other four were part of an operon homologous to the
spermidine transport system (PotA, D, B, C; an ABC transport system). The promoter
regions of PA1183 and the PA0603 operon were cloned into pSS269, which contained a
promoterless lacZ, and conjugated into PAO1, PDO401, and PDO406. Based on the
results of the assay, no significant difference in promoter activity was seen for either
PPA1183, or PPA0603 in the AlgB mutant strain compared to wild type. For the KinB mutant
strain, an opposite effect was observed with an increase in promoter activity, which was
significant for PPA0603 compared to PAO1. None of the β-galactosidase data correlated
to the microarray results. It was later found that overnight spread plates of

Pseudomonas culture were used to generate the microarray data, which was different
from the protocol I had used to perform the β-galactosidase assay. Since the RNA was
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collected from overnight cultures, the effects observed by microarray were not direct,
however, the results seen by the β-galactosidase assay were. This could explain the
discrepancy observed from the results that I had obtained compared to the results of
the microarray.
The second attempt to identify KinB/AlgB regulated genes was to perform the
ChIP-Seq assay. This was done in collaboration with Dr. Yuan Gao’s lab. My
responsibility was to conduct the chromatin immunoprecipitation assay, which was
initially done using the algB-kinB deletion strains carrying the His-AlgB variants (HisAlgBwt, His-AlgBE125K, and His-AlgBR442E), and utilizing the α-6X His Ab. The DNA
fragments obtained from the assay were verified by PCR amplifying PalgD and a
negative promoter, Pneg. This was to ensure binding of His-AlgBwt and His-AlgBE125K to
PalgD and no binding of His-AlgBR442E to any promoter. The negative promoter was to
confirm the absence of any random DNA that was not removed during the washing
process. I was able to collect DNA samples that seemed promising. PalgD amplified for
all three strains, however, the level of amplification seen by the DNA binding mutant
strain was significantly less than the other two. There were also no amplicons observed
for Pneg. These were sent to Dr. Gao’s lab for sequencing, but unfortunately, I was
informed that the total amount of DNA for each sample was equivalent. This was
unexpected, since the DNA binding mutant should not have bound to any DNA
promoters. The ChIP assay was redone with two modifications. JK159 was used as the
negative control strain, and the antibody was changed to α-AlgB Ab. Before I could use
the new antibody, I had to preabsorb it with lysates of JK159 to increase its specificity.
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The preabsorption process was verified by screening Western blots of Pseudomonas
lysates and once the best condition was determined this was used for the ChIP assay.
A more stringent preabsorbing condition was also used incorporating more lysed cells.
After PCR verifying the DNA samples, amplification of PalgD was still observed for all
three strains and at relatively similar levels; however, no amplicons for Pneg was seen.
It appeared that even the preabsorption process was not enough specificity for the αAlgB Ab. Since the negative mutant was completely absent of AlgB protein, the
antibody must be binding to another protein that also bound the algD promoter. It was
decided that next option would be to develop a monoclonal antibody for AlgB, which
would provide the highest level of specificity to the protein.

Chapter 7: Conclusions and future studies proposed

Pseudomonas aeruginosa, an opportunistic pathogen, is still the leading cause of
morbidity and mortality of CF patients. However, the current use of aggressive
prevention methods have partially contributed to the increased survival age of these
inflicted individuals (14). P. aeruginosa is capable of establishing and maintaining
disease because of its unique ability to survive in dynamic environments requiring
minimal carbon and nitrogen sources, its possession of a variety of virulence factors,
and its acquisition of numerous antibiotic resistant mechanisms (9, 21, 37, 44, 49).
Alginate is an important virulence factor associated with chronically infected CF lungs
and therefore, understanding the biomolecular basis of its regulation is clinically
significant. Extensive research on the regulation of this exopolysaccharide has been
conducted on strains that have undergone mucoid conversion isolated from the lungs of
these chronically infected individuals. The mucoid strains possess mutations in the antisigma factor, MucA, resulting in the deregulation of sigma 22. At least three other
major transcriptional activators are also involved in the expression of alginate including
AlgR, AlgB, and AmrZ, all of which are under sigma 22 control as well (5, 58, 92).
Further research has discovered another level of alginate regulation that occurs
indirectly with the tight control of the sigma factor by negative regulators, MucA and
MucB. MucA, an inner membrane protein, binds to MucB in the periplasm and tethers
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sigma 22 in the cytoplasm to the cytoplasmic membrane. Compounds affecting the
integrity of the outer membrane results in the proteolytic cleavage of MucA allowing for
the release of sigma 22. This sigma factor is then able to activate the transcription of
various genes and alginate (63, 90). A model of alginate regulation by sigma 22 is
shown in Figure 44.
An alternative mechanism of alginate regulation has been discovered based on
the results of this dissertation study. The focus of this research was to investigate one
of the major alginate transcriptional activators, AlgB, which was previously established
to be a member of the NtrC family of response regulators and part of a two-component
system with KinB (46, 91). The goal was to understand AlgB as a two-component
regulator in Pseudomonas and to examine the functional characteristics of the activated
state of this protein following phosphorylation. I was able to construct an overactive
mutant of AlgB by mimicking an amino acid change previously modified in a homologue,
DctD, which also resulted in an overactive form (55). The mutant, AlgBE125K,
unexpectedly induced the expression of alginate in a nonmucoid Pseudomonas strain at
the transcriptional level and is dependent upon sigma 54 (RpoN). These results provide
support of AlgB functioning as an overactive response regulator because transcriptional
activation of the algD promoter is continuously elevated, and requires a sigma factor
generally associated with NtrC family of regulators, sigma 54. Although alginate
induction occurred with the overactive mutant, the levels produced were never at the
levels seen for FRD1 or PDO300 (another mucA22 strain). It is possible that AlgBE125K
may not be the exact phosphomimic to provide the maximum level of AlgB activation
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Figure 44. Model illustrating the regulation of PalgD under sigma 22
control. Cell wall damage signals the cleavage of the periplasmic and cytoplasmic
domains of MucA. The cytoplasmic domain, which binds and tethers sigma 22 (AlgT)
to the membrane, is proteolytically degraded releasing sigma 22. This sigma factor is
then able to active transcription of itself, and other regulators of the algD operon.
These regulators together with sigma 22 bind to PalgD and activate the transcription
of alginate.
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and therefore alginate production. For future studies, I would randomly mutate AlgB
and determine which mutations induce alginate production in the nonmucoid strain,
PAO1. I would also measure and compare the amount of exopolysaccharide generated
by each mutation. It was surprising to discover that the activated state of AlgB
functioning as a response regulator is able to induce alginate production since previous
mutations of AlgB preventing its phosphorylation and the removal of KinB did not inhibit
alginate production in a strainwith a deregulated sigma 22 (FRD1) (45). Also
inactivation of sigma 54 (RpoN) in PDO300 did not affect the copious amount of
alginate generated by this strain. Based on these findings I believe that AlgT is
dominant for the regulation of alginate, and supersedes any other mechanism of control
when it becomes deregulated. Therefore, the effects of KinB/AlgB as a two-component
system on the algD operon could only be observed once sigma 22 is under tight control.
Competition is also shown between AlgT and RpoN, which becomes evident in
the presence of AlgBwt added in trans. Increased transcriptional activation of the algD
operon unexpectedly resulted following the mutation of sigma 22 in the presence of
AlgBwt. Even in the presence of both sigma factors, there was a significant 3-fold
increase in algD transcription, although this did not translate to detectable amounts of
uronic acid over background levels. However, this increase in transcript did indicate
transcriptional activation when sigma 54 was able to bind to the promoter since no
significant difference was seen compared to PAO1 after inactivation of sigma 54.
Published research has also observed competition between these same two sigma
factors and map overlapping binding sites (–35 and –10 for σ22; and –24 and –12 for
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σ54) within the algD promoter region (10). The results above suggest a higher affinity
for promoter binding by sigma 22, since full alginate induction by sigma 54 is only
observed after its removal. Therefore, even under complete regulation of σ22 (AlgT),
some of the sigma factor is still able to bind to the promoter preventing activation by
σ54 (RpoN).
The biochemical studies comparing AlgBwt to the overactive mutant, AlgBE125K,
presented interesting and unexpected results as well. The ATPase assay reveal an
intrinsic ability of AlgBwt to hydrolyze ATP without phosphorylation. Innate ATPase
activity has been previously demonstrated by two other homologues, DctD and NtrC1,
however, both are regulated by their N-terminal domains. Phosphorylation is required
to remove the inhibition and allow for ATP hydrolysis (42, 55). AlgB is the first member
of the NtrC family to exhibit ATPase activity with no dependence upon phosphorylation.
Since AlgBwt was able to intrinsically hydrolyze ATP, this would explain its ability to
interact with σ54 (RpoN) in the absence of σ22 (AlgT) promoting alginate transcription.
AlgBE125K also possessed ATPase activity at an equivalent rate compared to wild type.
Therefore, the overactive mutant’s ability to induce alginate production is not a result of
increased ATP hydrolysis.
For the EMSA studies, I was finally able to demonstrate AlgB binding to PalgD in

vitro, which has not been previously accomplished. Shifted EMSA bands were present
for AlgBwt and AlgBE125K, but the overactive mutant required more protein and
possessed a weaker band compared to wild type. Competition was also seen with the
addition of unlabeled specific probe for both proteins. However, the mutant and wild
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type AlgB possess an overall weak affinity for DNA since a large amount of protein is
required for binding shifts to occur and a large amount of unlabeled probe is needed for
competition. Attempts to optimize binding conditions were unsuccessful, although, I
still believe that a second binding site is present within PalgD, which would increase
binding affinity. Both NtrC and DctD have demonstrated cooperative binding to two
sites within their respective promoter regions (40, 62). The first effort to include a
possible second binding site for AlgB failed because the probe that was used was too
large, which probably inhibited any chance of protein binding. Future studies would
utilize shorter probes moving upstream and would include part of the initial specific
probe, which has shown binding. I hypothesize that a probe incorporating both AlgB
binding sites would demonstrate binding shifts requiring less protein and competition
using less unlabeled specific probe. Therefore, the initial hypothesis stating that
AlgBE125K bound DNA with a higher affinity than AlgBwt to allow for alginate production is
not true and is not the reason for the mutant’s overactive property.
One important characteristic of the NtrC family of response regulators in their
activated states is the process of oligomerization, which was not investigated in this
thesis study. It has been shown for NtrC that oligomerization is required for
transcriptional activation and elevated ATPase activity (24, 62). Also, binding of the
activated regulators results in DNA bending, which is important for interactions between
the activator and sigma 54 (13, 65). Native gel electrophoresis was performed on HisAlgBwt, His-AlgBE125K, and His-AlgBR442E as shown in Figure 45. Both AlgBwt and
AlgBE125K were of equal size in their native state since they migrated down the gel at the
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Figure 45. Native gel electrophoresis of His-AlgB constructs. Purified HisAlgBwt, His-AlgBE125K, and His-AlgBR442E were electrophoresed in a 10% polyacrylamide
gel under native buffer conditions. Coomassie stain was used to visualize the protein
bands.
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same rate. However, AlgBR442E ran faster than the other two proteins suggesting a
tighter folding complex as a result of the helix-turn-helix mutation. Unfortunately, the
multimeric state of these proteins under native conditions was unable to be determined.
NtrC and DctD have been shown to be dimers under normal buffer conditions, and
uponactivation in the presence of DNA, these dimers form higher order complexes.
However, there is still debate over whether this oligomerization process results in
hexamers or octomers (15, 66). Since the overactive mutant, AlgBE125K, did not display
an elevation in ATPase activity compared to wild type, an alternate hypothesis is
developed in which increased transcriptional activation of alginate by AlgBE125K is a
result of oligomerization at the algD promoter. This could explain the binding difference
that is seen for the EMSAs between AlgBE125K and AlgBwt. The shifted band observed
for the mutant was weaker than wild type; nevertheless, AlgBE125K definitely bound the
DNA probe because the band for unbound DNA was much less than the control
containing no protein. Since the shifted band for the overactive AlgB was fainter, larger
complexes could have formed that were too big to enter the gel, and therefore,
undetectable. Future research to assess the oligomerization hypothesis would first
involve size exclusion chromatography to determine whether AlgBwt and AlgBE125K form
dimers in their native states. Next, scanning electron microscopy would be used to
visualize possible higher order complexes of mutant AlgB bound to PalgD compared to
wild type. Finally, if the EM result shows support for the hypothesis, further research
involving ultracentrifugation analysis or methods to assess crystallized proteins would
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be performed in the presence of PalgD to examine whether the oligomerized state of
AlgBE125K resulted in hexamers or octomers.
Based on this research, an alternative model is developed to illustrate the
regulation of the algD operon by the KinB/AlgB two-component system (Figure 46). An
external signal, which has yet to be determined, stimulates the autophosphorylation
and activation of KinB at its highly conserved histidine residue. Phosphotransfer from
KinB to the aspartic acid residue of AlgB occurs resulting in the activation of the
regulator. Phosphorylated AlgB binds to PalgD and is believed to oligomerize.
Downstream of the AlgB binding site, sigma 54 attaches to the –24 and –12 regions
along with RNA polymerase (RNAP). The oligomerization of AlgB results in DNA
bending and allows for interactions with the sigma factor. The activated AlgB
hydrolyzes ATP providing the energy for open complex formation around the +1 start
site. Sigma 54-RNAP holoenzyme is then able to clear the promoter and transcription
of the algD operon occurs generating alginate.
This alternate level of regulation provides another method of alginate control
stimulated by signals in the environment that may be clinically relevant. Since these
signals to activate KinB are still unknown, it is possible that they may be present during
infection within the CF lung. Although many of the alginate-producing strains of P.

aeruginosa isolated from infected lungs have been identified to contain a deregulated
sigma 22 (48), there are those which have yet to be characterized. These mucoid
strains could be assessed for an altered KinB/AlgB system allowing for an overactive
AlgB or possibly an overactive KinB. Another possible role for this two-component
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system could occur early in infection. If the overactive AlgB mutant I created was in
fact a true phosphomimic, the low levels of alginate produced by this strain might be
required for its initial survival within the CF lung. KinB could be activated to allow for
induction of some alginate mediated by phosphorylated AlgB. These surviving bacteria
could then undergo a permanent mutation such as mucA22 producing copious amounts
of alginate for their persistence. In order to study the clinical relevance of this twocomponent system, methods to prevent the phosphorelay process such as
phosphorylation inhibitors could be used to determine the success of these strains in
colonizing the lung.
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Figure 46. Model illustrating the regulation of PalgD by the KinB/AlgB twocomponent system. The phosphorelay process is initiated by an unknown external
signal. Phosphorylated AlgB, indicated by the red star, binds to PalgD and
oligomerizes. Downstream, sigma 54-RNAP holoenzyme binds in closed complex
formation. The oligomerization of activated AlgB allows for DNA bending and
interaction with sigma 54. ATP hydrolysis by AlgB provides the energy needed for
open complex formation. The holoenzyme is then able to clear the promoter and the
algD operon is transcribed.
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